Skip to main content
SpringerLink
Log in
Book cover

Pediatric Infectious Diseases for the Practitioner pp 32–122Cite as

Antimicrobial Therapy

  • Chapter

Part of the book series: Comprehensive Manuals in Pediatrics ((CM PEDIATRICS))

Abstract

Antimicrobial therapy is a difficult subject for textbooks because of the rapid rate of development of agents and information about indications, pharmacokinetics, efficacy, and toxicity. Nevertheless, the practice of pediatrics, especially with respect to infectious diseases, would be paralyzed without the availability of these therapeutic agents, and the principles of their use and abuse remain somewhat constant.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aber RC, Wennersten C, Moellering RC Jr: Antimicrobial susceptibility of flavobacteria. Antimicrob Agents Chemother 14: 483–487, 1978.

    PubMed  CAS  Google Scholar 

  2. Abrams MS, Degnan TJ, Vinciguerra V: Marrow aplasia following topical application of chloramphenicol eye ointment. Arch Intern Med 140:576– 577, 1980.

    Google Scholar 

  3. Acocella G, Luvara A, Guaglianone M: Rifampin and the liver. Lancet ii: 45, 1978.

    Google Scholar 

  4. Adelman RD, Spangler WL, Beasom F, et al.: Furosemide enhancement of experimental gentamicin nephrotoxicity: comparison of functional and morphological changes with activities of urinary enzymes. J Infect Dis 140:342– 352, 1979.

    Google Scholar 

  5. Adkinson NF Jr, Thompson WL, Lichtenstein IM, et al.: Routine use of penicillin skin testing on an inpatient service. N Engl J Med 285: 22–24, 1971.

    PubMed  Google Scholar 

  6. Alban J: Efficacy of nystatin topical cream in the management of cutaneous candidiasis in infants. Curr Ther Res 14: 158–161, 1972.

    PubMed  CAS  Google Scholar 

  7. Alexander DP, Russo ME, Fohrman DE, et al.: Nafcillin–induced platelet dysfunction and bleeding. Antimicrob Agents Chemother 23: 59–62, 1983.

    PubMed  CAS  Google Scholar 

  8. Anderson EE, Anderson B Jr, Nashold BS: Childhood complications of nalidixic acid. JAMA 216: 1023–1024, 1971.

    PubMed  CAS  Google Scholar 

  9. Andrassay K, Ritz E, Koderisch J: Pseudoproteinuria in patients taking penicillin. Lancet ii: 154, 1978.

    Google Scholar 

  10. Andrassay K, Ritz E, Weisschedel E: Bleeding after carbenicillin administration. N Engl J Med 292: 109, 1975.

    Google Scholar 

  11. Andreoli SP, Kleiman MB, Glick MR, et al.: Nafcillin, pseudoproteinuria, and hypokalemic alkalosis. J Pediatr 97: 841–842, 1980.

    PubMed  CAS  Google Scholar 

  12. Arbeter AM, Saccar CL, Eisner S, et al.: Tobramycin sulfate elimination in premature infants. J Pediatr 103: 131–135, 1983.

    PubMed  CAS  Google Scholar 

  13. Arcieri G: Process of developing a new antimicrobial drug. Ann Intern Med 89: 838–841, 1978.

    PubMed  CAS  Google Scholar 

  14. Asmar BI, Magbool S, Dajani AS: Hematologic abnormalities after oral trimethoprim–sulfamethoxazole therapy in children. Am J Dis Child 135: 1100–1103, 1982.

    Google Scholar 

  15. Axelrod JL, Kochman RS: Cephradine levels in human aqueous humor. Arch Ophthalmol 99: 2034–2046, 1981.

    PubMed  CAS  Google Scholar 

  16. Axelrod J, Meyers BR, Hirschman SZ: 7–Chlorolincomycin therapy of pulmonary infections due to Mycoplasma pneumoniae. Antimicrob Agents Chemother 2: 499, 1972.

    PubMed  CAS  Google Scholar 

  17. Axline SG, Yaffe SJ, Simon HJ: Clinical pharmacology of antimicrobials in premature infants II. Ampicillin, methicillin, oxacillin, neomycin and col– istin. Pediatrics 39: 97–107, 1967.

    PubMed  CAS  Google Scholar 

  18. Ayres SM, Griesbach J, Giannelli Jr. S: A study of bronchial irritation and systemic absorption of aerosolized kanamycin. Curr Ther Res 14: 153, 1972.

    PubMed  CAS  Google Scholar 

  19. Azimi PH, Cramblett HG: Cephaloridine: clinical and laboratory studies in children. J Pediatr 73: 255–261, 1968.

    PubMed  CAS  Google Scholar 

  20. Azimi PH, Cramblett HG, del Rosario AJ, et al.: Cephalexin: treatment of streptococcal pharyngitis. Pediatrics 80: 1042, 1972.

    CAS  Google Scholar 

  21. Bach MC, Gold O, Finland M: Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar dilution and standard discdiffusion tests and with sulfadiazine in an experimental infection of mice. J Lab Clin Med 81: 787, 1973.

    PubMed  CAS  Google Scholar 

  22. Bagnarello AG, Lewis LA, McHenry MC: Unusual serum lipoprotein abnormality induced by the vehicle of miconazole. N Engl J Med 296:497– 499, 1977.

    Google Scholar 

  23. Baker LH, Hinthorn DR, Romig DA, et al.: Comparison of cefazolin levels in CSF and serum. Clin Res 22: 613A, 1974.

    Google Scholar 

  24. Balfour HH Jr: Resistance of Herpes simplex to acyclovir. Ann Intern Med 98: 404–406, 1983.

    PubMed  Google Scholar 

  25. Banner W Jr, Gooch WM III, Burckart G, et al.: Pharmacokinetics of nafcillin in infants with low birth weights. Antimicrob Agents Chemother 17:691– 694, 1980.

    Google Scholar 

  26. Barr WH, Gerbracht LM, Letcher K, et al.: Assessment of the biologic availability of tetracycline products in man. Clin Pharmacol Ther 13:97– 108, 1971.

    Google Scholar 

  27. Barrett SP, Watt PJ: Antibiotics and the liver. J Antimicrob Chemother 5: 337–348, 1979.

    PubMed  CAS  Google Scholar 

  28. Barrett–Connor E: Advice for young travelers. Pediatr Rev 1: 25–29, 1979.

    Google Scholar 

  29. Bartlett JG, Sutter VL, Finegold SM: Treatment of anaerobic infections with lincomycin and clindamycin. N Engl J Med 287: 1006–1010, 1972.

    PubMed  CAS  Google Scholar 

  30. Bartlett JG, Willey SH, Chang TW, et al.: Cephalosporin–associated pseu–domembranous colitis due to Clostridium difficile. JAMA 242: 2683–2685, 1979.

    PubMed  CAS  Google Scholar 

  31. Bass JW, Crowley DM, Steele RW, et al.: Adverse effects of orally administered ampicillin. J Pediatr 83: 106–108, 1973.

    PubMed  CAS  Google Scholar 

  32. Bass JW, Crowley DM, Steele RW, et al.: Ampicillin blood levels as related to graded oral schedules. Clin Pediatr 13: 273–279, 1974.

    CAS  Google Scholar 

  33. Ben–David A, Orgad S, Danon Y: HL–A antigen changes in patients treated with chloramphenicol. Tissue Antigens 3: 378–384, 1973.

    Google Scholar 

  34. Bennett JE: Chemotherapy of systemic mycoses (part 1). N Engl J Med 290: 30–32, 1974.

    PubMed  CAS  Google Scholar 

  35. Bennett JE: Chemotherapy of systemic mycoses (part 2). N Engl J Med 290: 320–323, 1974.

    PubMed  CAS  Google Scholar 

  36. Bennett WM, Singer I, Coggins CH: Guides to drug usage in adult patients with impaired renal function, JAMA 223: 991–997, 1973.

    PubMed  CAS  Google Scholar 

  37. Benowitz N, Forsyth RP, Melmon KL, et al.: Lidocaine disposition kinetics in monkey and man. 1. Prediction by a perfusion model. Clin Pharmacol Ther 16: 87, 1974.

    PubMed  CAS  Google Scholar 

  38. Bergan T, Michalsen H: Pharmacokinetic assessment of netilmicin in newborns and older children. Infection 10: 153–158, 1982.

    PubMed  CAS  Google Scholar 

  39. Berger SA, Barza M, Haher J, et al.: Penetration of clindamycin into decubitus ulcers. Antimicrob Agents Chemother 14: 498–499, 1978.

    PubMed  CAS  Google Scholar 

  40. Bermudez RH, Lugo A, Ramirez-Ronda CH, et al.: Amikacin sulfate levels in human serum and bile. Antimicrob Agents Chemother 19: 352–354, 1981.

    PubMed  CAS  Google Scholar 

  41. Biancaniello T, Meyer RA, Kaplan S: Chloramphenicol and cardiotoxicity. J Pediatr 98: 828–830, 1981.

    PubMed  CAS  Google Scholar 

  42. Bindschadler DD, Bennett JE: A pharmacologic guide to the clinical use of amphotericin B.J Infect Dis 120: 427, 1969.

    CAS  Google Scholar 

  43. Black SB, Levine P, Shinefield HR: The necessity for monitoring chloramphenicol levels when treating neonatal meningitis. J Pediatr 92: 235–236, 1978.

    PubMed  CAS  Google Scholar 

  44. Blair DC, Duggan DO, Schroeder ET: Inactivation of amikacin and gen– tamicin in patients with end–stage renal failure. Antimicrob Agents Chemother 22: 376–379, 1982.

    PubMed  CAS  Google Scholar 

  45. Blank H, Cullen SI, Catalona PM: Photosensitivity studies with demethylch– loretetracycline and doxycycline. Arch Dermatol 97: 1–2, 1968.

    PubMed  CAS  Google Scholar 

  46. Block SH: Carbamazepine–isoniazid interaction. Pediatrics 69: 494–495, 1982.

    PubMed  CAS  Google Scholar 

  47. Blumenthal DS: Intestinal nematodes in the United States. N Engl J Med 297: 1437–1439, 1977.

    PubMed  CAS  Google Scholar 

  48. Bodendorfer TW Nafcillin–induced interstitial nephritis. JAMA 244: 2609, 1980.

    PubMed  CAS  Google Scholar 

  49. Bomb RC, Bedi HK, Bhatnagar LK: Chloroquine psychosis. Trans Res Soc Trop Med Hyg 69: 523, 1982.

    Google Scholar 

  50. Bowersox DW, Winterbauer RH, Stewart GL, et al.: Isoniazid dosage in patients with renal failure. N Engl J Med 289: 84–87, 1973.

    PubMed  CAS  Google Scholar 

  51. Brass C, Galgiani JN, Blaschke TF: Disposition of ketoconazole, an oral antifungal in humans. Antimicrob Agents Chemother 21: 151, 1982.

    PubMed  CAS  Google Scholar 

  52. Brauner GJ: Bullous photoreaction to nalidixic acid. Am J Med 58:576– 580, 1975.

    Google Scholar 

  53. Breen KJ, Bryant RE, Levinson JD: Neonatal absorption in man. Studies of oral and enema administration and effect of intestinal ulceration. Ann Intern Med 76: 211–218, 1972.

    PubMed  CAS  Google Scholar 

  54. Bristritzer T, Barzilay Z, Jonas A: Isoniazid–rifampin–induced fulminant liver disease in an infant. J Pediatr 97: 480–482, 1980.

    Google Scholar 

  55. Brook I: Isolation of toxin producing Clostridium difficile from two children with oxacillin and dicloxacillin-associated diarrhea. Pediatrics 65: 1154–1156, 1980.

    PubMed  CAS  Google Scholar 

  56. Bruckstein AH, Attia AA: Oxacillin hepatitis. Two patients with liver biopsy, and review of the literature. Am J Med 64: 519–522, 1978.

    PubMed  CAS  Google Scholar 

  57. Brumfitt W, Pursell R: Double–blind trial to compare ampicillin, cephalexin, co-trimoxazole and trimethoprim in treatment of urinary infections. Br Med J 2: 673–676, 1972.

    PubMed  CAS  Google Scholar 

  58. Bryan CS, McFarland JA: Cryptococcal meningitis. Fatal marrow aplasia from combined therapy. JAMA 239: 1068–1069, 1978.

    PubMed  CAS  Google Scholar 

  59. Bryant RE, Rashad AL, Mazza JA, et al.: Lactamase activity in human pus. J Infect Dis 142: 594–601, 1980.

    PubMed  CAS  Google Scholar 

  60. Buchanan RA, Barrow WB, Heffelfinger JC, et al.: Pyrvinium pamoate. Clin Pharmacol Ther 16: 716–719, 1974.

    PubMed  CAS  Google Scholar 

  61. Bulger RJ: In vitro activity of cephalothin/kanamycin and methicillin/kan– amycin combinations against resistant Staphylococcus aureus. Lancet i: 17, 1967.

    Google Scholar 

  62. Burgess MA, Bodey GP: Clotrimoxazole (Bay 5097): In vitro and clinical pharmacology. Antimicrob Agents Chemother 2: 423, 1972.

    PubMed  CAS  Google Scholar 

  63. Burke FM Jr: Plague as seen in South Vietnamese children. Clin Pediatr 12: 291–298, 1973.

    Google Scholar 

  64. Burman LG, Brumfitt W, Hamilton–Miller JMT, et al.: Resistance to trimethoprim. Lancet i: 1409–1410, 1980.

    Google Scholar 

  65. Byrd RB, Nelson R, Eliott RC: Isoniazid toxicity. JAMA 220: 1471–1473, 1972.

    PubMed  CAS  Google Scholar 

  66. Cain GD, Reiner EB, Patterson M: Effects of neomycin and disaccharidase activity of the small bowel. Arch Intern Med 122: 311–314, 1968.

    PubMed  CAS  Google Scholar 

  67. Carling PC, Idelson BA, Casano AA, et al.: Nephrotoxicity associated with cephalothin administration. Arch Intern Med 135: 797–801, 1975.

    PubMed  CAS  Google Scholar 

  68. Carnevale NT, Galgiani JN, Stevens DA, et al.: Amphotericin B–induced myelopathy. Arch Intern Med 140: 1189–1192, 1980.

    PubMed  CAS  Google Scholar 

  69. Carpenter G: Chloramphenicol eye–drops and marrow aplasia. Lancet ii: 326 — 327, 1975.

    Google Scholar 

  70. Casale TB, Macher AB, Fauci AS: Complete hematologic and hepatic recovery in a patient with chloramphenicol hepatitis–pancytopenia syndrome. J Pediatr 101: 1025–1027, 1982.

    PubMed  CAS  Google Scholar 

  71. Chan CK, Balish E: Inhibition of granulocyte phagocytosis of Candida albicans by amphotericin B. Can J Microbiol 24: 363–364, 1978.

    PubMed  CAS  Google Scholar 

  72. Chan RA, Benner EJ, Hoeprich PD: Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med 76: 733–739, 1972.

    Google Scholar 

  73. Chan CSP, Tuazon CU, Lessin LS: Amphotericin B–induced thrombocytopenia. Ann Intern Med 96: 332, 1982.

    PubMed  CAS  Google Scholar 

  74. Chang JC, Reyes B: Agranulocytosis associated with gentamicin. JAMA 232: 1154–1155, 1975.

    PubMed  CAS  Google Scholar 

  75. Chapman JR, Warnock DW: Ketoconazole and fungal CAPD peritonitis. Lancet ii: 510–511, 1983.

    Google Scholar 

  76. Chavarria AP, Swartzwelder JC, Villarejos VM, et al.: Mebendazole, an effective broad–spectrum anthelmintic. Am J Trop Med Hyg 22: 592–595, 1973.

    PubMed  CAS  Google Scholar 

  77. Chow MSS, Quintiliani R, Nightingale CH: In vivo inactivation of tobramycin by ticarcillin. JAMA 247: 658–659, 1982.

    PubMed  CAS  Google Scholar 

  78. Chusid MJ, Atkins E: Studies on the mechanism of penicillin–induced fever. J Exp Med 136: 227, 1972.

    PubMed  CAS  Google Scholar 

  79. Clark AJL, Mouchizadeh J, Faunch R, et al.: Trimethoprim alone. Lancet i: 1030, 1980.

    Google Scholar 

  80. Cleary TG, Pickering LK, Kramer WG, et al.: Amikacin pharmacokinetics in pediatric patients with malignancy. Antimicrob Agents Chemother 16: 829–832, 1979.

    PubMed  CAS  Google Scholar 

  81. Cohen HN, Beastall GH, Ratcliffe WA, et al.: Effects on human thyroid function of sulphonamide and trimethoprim combination drugs. Br Med J 281: 646–647, 1980.

    PubMed  CAS  Google Scholar 

  82. Cohen LK, George W, Smith R: Isoniazid–induced acne and pellagra. Arch Dermatol 109: 377–381, 1974.

    PubMed  CAS  Google Scholar 

  83. Colding H, Andersen GE: Stability of antibiotics and amino acids in two synthetic L–amino acid solutions commonly used for total parenteral nu–trition in children. Antimicrob Agents Chemother 13: 555–558, 1978.

    PubMed  CAS  Google Scholar 

  84. Cole JJ, Charles BG, Ravenscroft PJ: Interaction of cimetidine with tetra–cycline absorption. Lancet ii: 536, 1980.

    Google Scholar 

  85. Colvard MC Jr: Respiratory paralysis secondary to the use of polymyxin B. South Med J 64: 652, 1971.

    PubMed  Google Scholar 

  86. Commentary: An appraisal of tobramycin usage in pediatrics. J Pediatr 88: 315–317, 1976.

    Google Scholar 

  87. Congeni BL, Tan J, Salstrom SJ, et al.: Kinetics of vancomycin after intraventricular and intravenous administration. Pediatr Res 13: 459, 1979.

    Google Scholar 

  88. Cook FV, Farrar WE: Vancomycin revisited. Ann Intern Med 88: 813–818, 1978.

    PubMed  CAS  Google Scholar 

  89. Coster DJ, McKinnon JR, McGill JI, et al.: Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus. J Infect Dis 133: A173–177, 1976.

    PubMed  Google Scholar 

  90. Craft JC, Murphy T, Nelson JD: Furazolidone and quinacrine. Am J Dis Child 135: 164–166, 1981.

    PubMed  CAS  Google Scholar 

  91. Craig WA, Kunin CM: Trimethoprim–sulfamethoxazole pharmacodynamic effects of urinary pH and impaired renal function. Ann Intern Med 78: 491–496, 1973.

    PubMed  CAS  Google Scholar 

  92. Cutler RE, Gyselynck AM, Fleet P, et al.: Correlation of serum creatinine concentration and gentamicin half–life. JAMA 219: 1037–1041, 1972.

    PubMed  CAS  Google Scholar 

  93. Cutler RE, Orme BM: Correlation of serum creatine concentration and kanamycin half–life. JAMA 209: 539–542, 1969.

    PubMed  CAS  Google Scholar 

  94. Czerwinski AW, Pederson JA, Barry JP: Cefazolin plasma concentrations and urinary excretion in patients with renal impairment. J Clin Pharmacol 14: 560–566, 1974.

    PubMed  CAS  Google Scholar 

  95. D’Oliveira JJG: Cerebrospinal fluid concentrations of rifampin in meningeal tuberculosis. Am Rev Respir Dis 106: 432–437, 1972.

    PubMed  Google Scholar 

  96. Davis CM, Vandersarl JV, Kraus EW: Tetracycline inequivalence: the im–portance of 96–hour testing. Am J Med Sci, 265: 69, 1973.

    PubMed  CAS  Google Scholar 

  97. DeHaan RM, Schellenberg A: Clindamycin palmitate flavored granules. multidose tolerance, absorption and urinary excretion study in healthy children. J Clin Pharmacol 12: 74, 1972.

    CAS  Google Scholar 

  98. Denys GA, Jerris RC, Swenson JM, et al.: Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents. Antimicrob Agents Chemother 23: 335–337, 1983.

    PubMed  CAS  Google Scholar 

  99. DeSante KA, Israel KS, Brier GL, et al.: Effect of probenecid on the pharmacokinetics of moxalactam. Antimicrob Agents Chemother 21: 58–61, 1982.

    PubMed  CAS  Google Scholar 

  100. DeVito GA Jr: Transient evaluation of alkaline phosphatase possibly related to trimethoprim–sulfamethoxazole therapy. J Pediatr 100: 998–999, 1982.

    PubMed  Google Scholar 

  101. Dickie KJ, de Groot WJ: Ventilatory effects of aerosolized kanamycin and polymyxin. Chest 63: 69, 1973.

    Google Scholar 

  102. Dobkin JF, Saha JR, Butler VP, et al.: Effects of antibiotic therapy on digoxin metabolism. Clin Res 30: 517A, 1982.

    Google Scholar 

  103. Doern GV, Siebers KG, Hallick LM, et al.: Antibiotic susceptibility of Beta– lactamase–producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother 17: 24–29, 1980.

    PubMed  CAS  Google Scholar 

  104. Dolin R, Reichman RC, Madore HP, et al.: A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 307: 580–584, 1982.

    PubMed  CAS  Google Scholar 

  105. Dominguez–Vazquez A, Taylor HR, Greene BM, et al.: Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. Lancet i: 139–143, 1983.

    Google Scholar 

  106. Doster B, Murray FJ, Newman R, et al.: Ethambutol in the initial treatment of pulmonary tuberculosis. Am Rev Respir Dis 107: 177–190, 1973.

    PubMed  CAS  Google Scholar 

  107. Drummer S, Hauser WE Jr, Remington JS: Antabuse–like effect of yS–lactam antibiotics. N Engl J Med 303: 1417–1418, 1980.

    PubMed  CAS  Google Scholar 

  108. Drutz DJ, Spickard A, Rogers DE, et al.: Treatment of disseminated mycotic infections. Am J Med 45: 405–418, 1968.

    PubMed  CAS  Google Scholar 

  109. Dupont HL, Hornick RB, Weiss CF, et al.: Evaluation of chloramphenicol acid succinate therapy of induced typhoid fever and Rocky Mountain spotted fever. N Engl J Med 282: 53–57, 1970.

    PubMed  CAS  Google Scholar 

  110. Dzink J, Bartlett JG: In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic–associated diarrhea or colitis. Antimicrob Agents Chemother 17: 695–698, 1980.

    PubMed  CAS  Google Scholar 

  111. Edwards D, Normand ICS, Prescod N: Disappearance of vesicoureteric reflux during long–term prophylaxis of urinary tract infection in children. Br Med J 2: 285–288, 1977.

    PubMed  CAS  Google Scholar 

  112. Eggleston DJ: Procaine penicillin psychosis. Br Dent J 148: 73–74, 1980.

    PubMed  CAS  Google Scholar 

  113. Eichenwald HF, McCracken GH: Antimicrobial therapy in infants and children. Part 1. Review of antimicrobial agents. J Pediatr 93: 337–377, 1978.

    PubMed  CAS  Google Scholar 

  114. Eickhoff TC, Marks MI: Carbenicillin in therapy of systemic infections due to Pseudomonas. J Infect Dis 122: S84–86, 1970.

    PubMed  Google Scholar 

  115. Eisner EV, Kasper K: Immune thrombocytopenia due to a metabolite of para–aminosalicylic acid. Am J Med 53: 790–796, 1972.

    PubMed  CAS  Google Scholar 

  116. Enat R, Pollack S, Ben–Arieh Y: Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs. Br Med J 1: 982–983, 1980.

    Google Scholar 

  117. Eneroth CM, Lundberg C, Wretlind B: Antibiotic concentrations in maxillary sinus secretions and in the sinus mucosa. Chemotherapy 21: 1–7, 1975.

    PubMed  Google Scholar 

  118. Eng RHK, Person A, Mangura C: Susceptibility of Zygomycetes to amphotericin B, miconazole, and ketoconazole. Antimicrob Agents Chemother 20: 688–690, 1981.

    PubMed  CAS  Google Scholar 

  119. Ericsson CD, Feldman S, Pickering LK, et al.: Influence of subsalicylate bismuth on absorption of doxycycline. J Am Med 247: 2266–2267, 1982.

    CAS  Google Scholar 

  120. Evaskus DS, Laskin DM, Kraeger AV: Penetration of lincomycin, penicillin, and tetracycline into serum and bone. Proc Soc Exp Biol Med 30: 89, 1969.

    Google Scholar 

  121. Fainstein V, Bodey GP: Cardiorespiratory toxicity due to miconazole. Ann Intern Med 93: 432–433, 1980.

    PubMed  CAS  Google Scholar 

  122. Fainstein V, Weaver S, Bodey GP: In vitro susceptibilities of Aeromonas hydrophila against new antibiotics. Antimicrob Agents Chemother 22:513– 514, 1982.

    Google Scholar 

  123. Farber BF, Moellering RC Jr: Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 23: 138–141, 1983.

    PubMed  CAS  Google Scholar 

  124. Fass RJ: Treatment of osteomyelitis and septic arthritis with cefazolin. Antimicrob Agents Chemother 13: 405–411, 1978.

    PubMed  CAS  Google Scholar 

  125. Fass RJ, Barnishan J: In vitro susceptibilities of Aeromonas hydrophila to 32 antimicrobial agents. Antimicrob Agents Chemother 19: 357–358, 1981.

    PubMed  CAS  Google Scholar 

  126. Fass RJ, Scholand JF, Hodges GR, et al.: Clindamycin in the treatment of serious anaerobic infections. Ann Intern Med 78: 853–859, 1973.

    PubMed  CAS  Google Scholar 

  127. Feder HM Jr: Chemoprophylaxis in ambulatory pediatrics. Pediatr Infect Dis 2: 251–257, 1983.

    PubMed  Google Scholar 

  128. Feely J: Sodium depletion enhances nephrotoxicity of amphotericin B. Lancet i: 1422–1423, 1981.

    Google Scholar 

  129. Feigin RD, Moss KS, Shackelford PG: Antibiotic stability in solutions used for intravenous nutrition and fluid therapy. Pediatrics 51: 1016, 1973.

    PubMed  CAS  Google Scholar 

  130. Feigin RD, Pickering LK, Anderson D, et al.: Clindamycin treatment of osteomyelitis and septic arthritis in children. Pediatrics 55: 213–223, 1975.

    PubMed  CAS  Google Scholar 

  131. Feigin RD, Van Reken DE, Pickering LK: Dosage in methicillin–associated nephropathy. J Pediatr 85: 734–735, 1974.

    PubMed  CAS  Google Scholar 

  132. Feldman HA: Toxoplasmosis. N Engl J Med 279:1370–1375; 1431–1437, 1968.

    Google Scholar 

  133. Feldman WE, Nelson JD, Stanberry LR: Clinical and pharmacokinetic evaluation of nafcillin in infants and children. J Pediatr 93: 1029–1033, 1978.

    PubMed  CAS  Google Scholar 

  134. Felegie TP, Yu VL, Rumans LW, et al.: Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 16: 833–837, 1979.

    PubMed  CAS  Google Scholar 

  135. Felts JH, Hayes DM, Gergen JA, et al.: Neural, hematologic and bacteriologic effects of nitrofurantoin in renal insufficiency. Am J Med 51: 331–339, 1971.

    PubMed  CAS  Google Scholar 

  136. Fenske NA, Millns JL, Greer KE: Minocycline–induced pigmentation at sites of cutaneous inflammation. JAMA 244: 1103–1106, 1980.

    PubMed  CAS  Google Scholar 

  137. Ferguson RM, Sutherland DE, Simmons RL, et al.: Ketoconazole, cyclosporin metabolism, and renal transplantation. Lancet ii: 882–883, 1982.

    Google Scholar 

  138. Fisher JF, Dewald J: Parkinsonism associated with intraventricular amphotericin B. J Antimicrob Chemother 12: 97–99, 1983.

    PubMed  CAS  Google Scholar 

  139. Fisher JF, Duma RJ, Markowitz SM, et al.: Therapeutic failures with miconazole. Antimicrob Agents Chemother 13: 965–968, 1978.

    PubMed  CAS  Google Scholar 

  140. Fitzpatrick JE, Tyler H Jr, Gramstad ND: Treatment of chancroid, comparison of sulfamethoxazole–trimethoprim with recommended therapies. JAMA 246: 1804–1805, 1981.

    PubMed  CAS  Google Scholar 

  141. Fleming AF, Warrell DA, Dickmeiss H: Co–trimoxazole and the blood. Lancet ii: 284–285, 1974.

    Google Scholar 

  142. Flynn CT, Rainford DJ, Hope E: Acute renal failure and rifampicin: danger of unsuspected intermittent dosage. Br Med J 2: 482, 1974.

    PubMed  CAS  Google Scholar 

  143. Food and Drug Administration Bulletin: Alcohol–drug interactions. 9: 10, 1979.

    Google Scholar 

  144. Forlenza SW, Newman MG, Horikoshi AL, et al.: Antimicrobial susceptibility of Capnocytophaga. Antimicrob Agents Chemother 19: 144–146, 1981.

    PubMed  CAS  Google Scholar 

  145. Forsgren A, Gnarpe H: Tetracycline interference with the bactericidal effect of serum. Nature (New Biol) 244: 82–83, 1973.

    CAS  Google Scholar 

  146. Fulton JE Jr: Miconazole therapy for endemic fungal disease. Arch Dermatol 111: 596, 1975.

    PubMed  Google Scholar 

  147. Gantz NM, Zawacki JK, Dickerson J, et al.: Pseudomembranous colitis as–sociated with erythromycin. Ann Intern Med 91: 866–867, 1979.

    PubMed  CAS  Google Scholar 

  148. Garibaldi RA, Drusin RE, Ferebee SH, et al.: Isoniazid–associated hepatitis. Report of an outbreak. Am Rev Respir Dis 106: 357–365, 1972.

    PubMed  CAS  Google Scholar 

  149. Gentry LO, Jemsek JG, Natelson EA: Effects of sodium piperacillin on platelet function in normal volunteers. Antimicrob Agents Chemother 19: 532–533, 1981.

    PubMed  CAS  Google Scholar 

  150. Geraci JE: Vancomycin. Mayo Clin Proc 52: 631–634, 1977.

    CAS  Google Scholar 

  151. Ghishan FK: Trimethoprim–sulfamethoxazole–induced intrahepatic cholestasis. Clin Pediatr 22: 212–214, 1983.

    CAS  Google Scholar 

  152. Ginsburg CM, McCracken GH Jr: Pharmacokinetics of cephradine suspension in infants and children. Antimicrob Agents Chemother 16: 74–76, 1979.

    PubMed  CAS  Google Scholar 

  153. Ginsburg CM, McCracken GH Jr, Olsen K: Pharmacology of ketoconazole suspension in infants and children. Antimicrob Agents Chemother 23:787– 789, 1983.

    Google Scholar 

  154. Ginsburg CM, McCracken GH Jr, Petruska M, et al.: Effect of feeding on bioavailability of griseofulvin in children. J Pediatr 102: 309–311, 1983.

    PubMed  CAS  Google Scholar 

  155. Ginsburg CM, McCracken GH Jr, Zweighaft TC, et al.: Comparative phar–macokinetics of cyclacillin and amoxicillin in infants and children. Antimicrob Agents Chemother 19: 1086–1088, 1981.

    PubMed  CAS  Google Scholar 

  156. Gnarpe H, Leslie D: Tetracycline and host defense mechanisms, doxycycline interference with phagocytosis of Escherichia coli. Microbios 10A: 138, 1974.

    Google Scholar 

  157. Graber CD, Jebaily J, Galphin RL, et al.: Light chain proteinuria and humoral immunocompetence in tuberculous patients treated with rifampin. Am Rev Respir Dis 107: 713–717, 1973.

    PubMed  CAS  Google Scholar 

  158. Graft DF, Chesney PJ: Use of ticarcillin following carbenicillin–associated hepatotoxicity. J Pediatr 100: 497–499, 1982.

    PubMed  CAS  Google Scholar 

  159. Gralnick HR, McGinniss M, Halterman R: Thrombocytopenia with sodium cephalothin therapy. Ann Intern Med 77: 401–404, 1972.

    PubMed  CAS  Google Scholar 

  160. Graybill JR, Herndon JH, Kniker WT, et al.: Ketoconazole treatment of chronic mucocutaneous candidiasis. Arch Dermatol 116: 1137–1141, 1980.

    PubMed  CAS  Google Scholar 

  161. Green RL, Lewis JE, Stephen BS, et al.: Elevated plasma procaine concentrations after administration of procaine penicillin G. N Engl J Med 291:223– 226, 1974.

    Google Scholar 

  162. Green GR, Rosenblum A: Report of the penicillin study group—American Academy of Allergy. J Allergy Clin Immunol 48: 331–343, 1971.

    PubMed  CAS  Google Scholar 

  163. Green WH, Moody M, Schimpff S, et al.: Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Ann Intern Med 79: 684–689, 1973.

    Google Scholar 

  164. Greenstone G, Hammerberg S, Marks MI: In vitro activity of netilmicin (SCH 20569) against bacterial isolates from ill children. Chemotherapy 24: 29–33, 1978.

    PubMed  CAS  Google Scholar 

  165. Grossman ER, Walchek A, Freedman H: Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics 47: 567–570, 1971.

    PubMed  CAS  Google Scholar 

  166. Guerra R, Casu L: Hydroxycobalamin for ethambutol–induced optic neuropathy. Lancet ii: 1176, 1981.

    Google Scholar 

  167. Gutmann L, Goldstein FW, Kitzis MD, et al.: Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 ß-lactams. Antimicrob Agents Chemother 23: 248–251, 1983.

    PubMed  CAS  Google Scholar 

  168. Hailey FJ, Glascock HW Jr, Hewitt WF: Pleuropneumonic reactions to nitrofurantoin. N Engl J Med 281: 1087–1090, 1969.

    PubMed  CAS  Google Scholar 

  169. Halprin GM, McMahon SM: Cephalexin concentrations in sputum during acute respiratory infections. Antimicrob Agents Chemother 3: 703, 1973.

    PubMed  CAS  Google Scholar 

  170. Halsted CH, Mclntyre PA: Intestinal malabsorption caused by aminosalicylic acid therapy. Arch Intern Med 130: 935–939, 1972.

    PubMed  CAS  Google Scholar 

  171. Hammond GW, Lian CJ, Wilt JC, et al.: Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother 13: 608–612, 1978.

    PubMed  CAS  Google Scholar 

  172. Hann IM, Prentice HG, Keaney M, et al.: The pharmacokinetics of keto– conazole in severely immunocompromised patients. J Antimicrob Chemother 10: 489–496, 1982.

    PubMed  CAS  Google Scholar 

  173. Hanna C, Massey JY, Hendrickson RO, et al.: Ocular penetration of topical chloramphenicol in humans. Arch Ophthalmol 96: 1258–1261, 1978.

    PubMed  CAS  Google Scholar 

  174. Harpey J–P, Darbois Y, Lefebvre G: Teratogenicity of pyrimethamine. Lancet ii: 399, 1983.

    Google Scholar 

  175. Hash JH: Antibiotic mechanisms. Annu Rev Pharmacol 12: 35, 1972.

    PubMed  CAS  Google Scholar 

  176. Hassall C, Feetam CL, Leach RH, et al.: Potentiation of warfarin by co– trimoxazole. Lancet ii: 1155 — 1156, 1975.

    Google Scholar 

  177. Hamilton HE, Sheets RF: Sulfisoxazole–induced thrombocytopenia purpura. JAMA 239: 2586–2587, 1978.

    PubMed  CAS  Google Scholar 

  178. Heel RC, Brogden RN, Pakes GE, et al.: Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs 19: 7–30, 1980.

    PubMed  CAS  Google Scholar 

  179. Heiberg JK, Svejgaard E: Toxic hepatitis during ketoconazole treatment. Br Med J 283: 825–826, 1981.

    CAS  Google Scholar 

  180. Hieber JP, Kusmiesz H, Nelson JD: Kanamycin in children: pharmacology and lack of toxicity of an increased dosage regimen. J Pediatr 96:1089– 1091, 1980.

    Google Scholar 

  181. Hieber JP, Nelson JD: A pharmacologic evaluation of penicillin in children with purulent meningitis. N Engl J Med 297: 410–413, 1977.

    PubMed  CAS  Google Scholar 

  182. Hinver LB, Baluarte HJ, Polinsky MS, et al.: Cefazolin in children with renal insufficiency. J Pediatr 96: 335–339, 1980.

    Google Scholar 

  183. Hnatko SI: The treatment of acute and chronic staphylococcal osteomyelitis and soft tissue infections with lincomycin. Can Med Assoc J 97: 580–584, 1967.

    PubMed  CAS  Google Scholar 

  184. Hobby GL, Lenert TF: Observations on the action of rifampin and etham– butol alone and in combination with other antituberculous drugs. Am Rev Respir Dis 105: 292–295, 1972.

    PubMed  CAS  Google Scholar 

  185. Hodges GR, Saslaw S: Experiences with cefazolin: a new cephalosporin antibiotic. Am J Med Sci 265: 23, 1973.

    PubMed  CAS  Google Scholar 

  186. Hoecker JL, Pickering LK, Swaney J, et al.: Clinical pharmacology of tobramycin in children. J Infect Dis 137: 592–596, 1978.

    PubMed  CAS  Google Scholar 

  187. Hoffler U, Niederau W, Pulverer G: Susceptibility of Bacterium actinomycetem– comitans to 45 antibiotics. Antimicrob Agents Chemother 17: 943–946, 1980.

    PubMed  CAS  Google Scholar 

  188. Holt RJ, Newman RL: Laboratory assessment of the antimycotic drug clotrimazole. J Clin Pathol 25: 1089, 1972.

    PubMed  CAS  Google Scholar 

  189. Horsburg Jr. CR, Kirkpatrick CH, Teutsch CB: Ketoconazole and the liver. Lancet i: 860, 1982.

    Google Scholar 

  190. Howarth WR, Korfhagen TR, Loper JC, et al.: Pseudomonas aeruginosa R factors determining gentamicin plus carbenicillin resistance from patients with urinary tract colonization. Antimicrob Agents Chemother 7: 64–68, 1975.

    Google Scholar 

  191. Hugh TB, Coleman MJ: Fish fanciers finger: tropical fish–tank granuloma. Med J Aust 1: 614–615, 1981.

    PubMed  CAS  Google Scholar 

  192. Hughes WT, Feldman S, Chaudhary SC, et al.: Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 92: 285–291, 1978.

    PubMed  CAS  Google Scholar 

  193. Hughes WT, Feldman S, Sanyal SK: Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole. Can Med Assoc J 112:47S– 50S, 1975.

    Google Scholar 

  194. Hughes WT, Kunh S, Chaudhary S, et al.: Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297: 1419–1426, 1977.

    PubMed  CAS  Google Scholar 

  195. Hulbert J: Urinary tract infection and oral penicillin G:J Clin Pathol 25: 73, 1972.

    CAS  Google Scholar 

  196. Hurwitz A, Scholozman DL: Effects of antacids on gastrointestinal absorption of isoniazid in rat and man. Am Rev Respir Dis 109: 41–47, 1974.

    PubMed  CAS  Google Scholar 

  197. Inagaki J, Bodey GP: Plebitis associated with cephalosporins: cephapirin versus cephalothin. Curr Ther Res 15: 37, 1973.

    PubMed  CAS  Google Scholar 

  198. Ing TS, Daugirdas JT, Soung LS, et al.: Toxic effects of amantadine in patients with renal failure. Can Med Assoc J 120: 695–698, 1979.

    PubMed  CAS  Google Scholar 

  199. Ismail MA, Lerner SA: Disseminated blastomycosis in a pregnant woman. Review of amphotericin B usage during pregnancy. Am Rev Respir Dis 126: 350–353, 1982.

    PubMed  CAS  Google Scholar 

  200. Jacobs J, Kletter D, Superstine E, et al.: Intravenous infusions of heparin and penicillins. J Clin Pathol 26: 742, 1973.

    PubMed  CAS  Google Scholar 

  201. Jager-Roman E, Doyle PE, Baird-Lambert J, et al.: Pharmacokinetics and tissue distribution of metronidazole in the newborn infant. J Pediatr 100: 651–654, 1982.

    PubMed  CAS  Google Scholar 

  202. Orris DJ, Lewis JH, Spero JA, et al.: Blocking coagulation inhibitors in children taking penicillin. J Pediatr 97: 426–429, 1980.

    PubMed  CAS  Google Scholar 

  203. Jeanes CWL, Jessamine AG, Eidus L: Treatment of chronic drug–resistant pulmonary tuberculosis with rifampin and ethambutol. Can Med Assoc J 106: 884, 1972.

    PubMed  CAS  Google Scholar 

  204. Jenson HA, Halveg AB, Saunamaki KI: Permanent impairment of renal function after methicillin nephropathy. Br Med J 4: 406–407, 1971.

    Google Scholar 

  205. Jordon WM, Bodey GP, Rodriguez V, et al.: Miconazole therapy for treatment of fungal infections in cancer patients. Antimicrob Agents Chemother 16: 792–797, 1979.

    Google Scholar 

  206. Jorgensen JH, Crawford SA: Selective inactivation of aminoglycosides by new beta–lactam antibiotics. Curr Ther Res 32: 25–35, 1982.

    CAS  Google Scholar 

  207. Jusko WJ, Mosovich LL, Gerbracht LM, et al.: Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 56: 1038–1044, 1975.

    PubMed  CAS  Google Scholar 

  208. Kalbian W: Deafness following oral use of neomycin. South Med J 65: 499–500, 1972.

    PubMed  CAS  Google Scholar 

  209. Kalowski S, Radford N, Kincaid–Smith P: Crystalline and macrocrystalline nitrofurantoin in the treatment of urinary tract infection. N Engl J Med 290: 385–387, 1974.

    PubMed  CAS  Google Scholar 

  210. Kampmann J, Kansen JM, Siersbaek-Neilsen K, et al.: Effect of some drugs on penicillin half–life in blood. Clin Pharmacol Ther 13: 516–519, 1972.

    PubMed  CAS  Google Scholar 

  211. Kan SP: Efficacy of single doses of mebendazole in the treatment of Trichuris trichiura infection. Am J Trop Med Hyg 32: 118–122, 1983.

    PubMed  CAS  Google Scholar 

  212. Kaplan SL, Mason EO, Garcia H, et al.: Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. J Pediatr 98: 152–157, 1981.

    PubMed  CAS  Google Scholar 

  213. Kaplan JM, McCracken GH Jr, Horton LJ: Pharmacologic studies in neonates given large dosages of ampicillin. J Pediatr 84: 571–577, 1974.

    PubMed  CAS  Google Scholar 

  214. Kasanen A, Raines T, Sundqvist H, et al.: Doxycycline in renal insufficiency. Curr Ther Res 16: 243–250, 1974.

    PubMed  CAS  Google Scholar 

  215. Kauffman RE, Shoeman DW, Wan SH, et al.: Absorption and excretion of clindamycin–2–phosphate in children after intramuscular injection. Clin Pharmacol Ther 13: 704–709, 1972.

    PubMed  CAS  Google Scholar 

  216. Kaye D: Summary of symposium on Cefazolin. J Infect Dis 128: S442, 1973.

    Google Scholar 

  217. Kearns GL, Hillman BC, Wilson JT: Dosing implications of altered gen– tamicin disposition in patients with cystic fibrosis. J Pediatr 100: 312–318, 1982.

    PubMed  CAS  Google Scholar 

  218. Keating JP, Frand AL, Barton LL, et al.: Pseudomembranous colitis associated with ampicillin therapy. Am J Dis Child 128: 369–370, 1974.

    PubMed  CAS  Google Scholar 

  219. Kelly HB, Menendez R, Fan L: Pharmacokinetics of tobramycin in cystic fibrosis. J Pediatr 100: 318–321, 1982.

    PubMed  CAS  Google Scholar 

  220. Kemmerich B, Lode H, Borner K: Biliary excretion and pharmacokinetics of cefoperazone in humans. J Antimicrob Chemother 12: 27–37, 1983.

    PubMed  CAS  Google Scholar 

  221. Kenwright S, Levi AJ: Impairment of hepatic uptake of rifamycin antibiotics by probenecid and its therapeutic implications. Lancet ii: 1401, 1973.

    Google Scholar 

  222. Kerns DL, Shira JE, Go S, et al.: Ampicillin rash in children. Am J Dis Child 125: 187–190, 1973.

    PubMed  CAS  Google Scholar 

  223. Kesarwala HH, Rahill WJ, Amaram N: Vancomycin induced neutropenia. Lancet i: 1423, 1981.

    Google Scholar 

  224. KeystoneJS, Murdoch JK: Mebendazole. Ann Intern Med 91: 582–586, 1979.

    Google Scholar 

  225. Khan AJ: Clinical and laboratory evaluation of cefazolin: a new cephalosporin antibiotic in pediatric patients. Curr Ther Res 15: 727–733, 1973.

    PubMed  CAS  Google Scholar 

  226. Kind AC, Tupasi TE, Standiford HC, et al.: Mechanisms responsible for plasma levels of nafcillin lower than those of oxacillin. Arch Intern Med 125: 685–688, 1970.

    PubMed  CAS  Google Scholar 

  227. Klein JO, Schaberg MJ, Buntin M, et al.: Levels of penicillin in serum of newborn infants after single intramuscular doses of benzathine penicillin G.J Pediatr 82: 1065–1068, 1973.

    CAS  Google Scholar 

  228. Kliegman RM, Bertino JS Jr, Fanaroff AA, et al.: Pharmacokinetics of gentamicin during exchange transfusions in neonates. J Pediatr 96: 927–930, 1980.

    PubMed  CAS  Google Scholar 

  229. Klimek JJ, Bates TR, Nightingale C: Penetration characteristics of trimethoprim-sulfamethoxazole in middle ear fluid of patients with chronic serous otitis media. J Pediatr 96: 1087–1089, 1980.

    PubMed  CAS  Google Scholar 

  230. Knight R: The chemotherapy of amoebiasis. J Antimicrob Chemother 6:577– 593, 1980.

    Google Scholar 

  231. Koldin MH, Medoff G: Antifungal chemotherapy. Pediatr Clin North Am 30: 49–61, 1983.

    PubMed  CAS  Google Scholar 

  232. Kolyvas E, Ahronheim GA, Marks MI: Oral antibiotic therapy of skeletal infections in children. Pediatrics 65: 867–871, 1980.

    PubMed  CAS  Google Scholar 

  233. Konish H, Goto M, Nakamoto Y, et al.: Tobramycin inactivation by car– benicillin, ticarcillin, and piperacillin. Antimicrob Agents Chemother 23: 653–657, 1983.

    Google Scholar 

  234. Koup JR, Gibaldi M, McNamara P, et al.: Interaction of chloramphenicol with phenytoin and phenobarbital. Clin Pharmacol Ther 24: 571–575, 1978.

    PubMed  CAS  Google Scholar 

  235. Kovnat P, Labovitz E, Levison SP: Antibiotics and the kidney. Med Clin North Am 57: 1045, 1973.

    PubMed  CAS  Google Scholar 

  236. Kramer PW, Griffith RS, Campbell RL: Antibiotic penetration of the brain a comparative study. J Neurol 31: 295, 1969.

    CAS  Google Scholar 

  237. Krogstad DJ, Spencer HC Jr, Healy GR: Amebiasis. N Engl J Med 298:262– 265, 1978.

    Google Scholar 

  238. Krowchuk D, Seashore J: Complete biliary obstruction due to erythromycin estolate administration in an infant. Pediatrics 64: 956–958, 1979.

    PubMed  CAS  Google Scholar 

  239. Kuck NA: In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea–Mima). Antimicrob Agents Chemother 9: 493–497, 1976.

    PubMed  CAS  Google Scholar 

  240. Kusumi RK, Plouffe JF, Wyatt RH, et al.: Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med 93: 59–60, 1980.

    PubMed  CAS  Google Scholar 

  241. L’Hommedieu C, Stough R, Brown L, et al.: Potentiation of neuromuscular weakness in infant botulism by aminoglycosides. J Pediatr 95: 1065–1070, 1979.

    PubMed  Google Scholar 

  242. Labovitz E, Levison ME, Kaye D: Single–dose daily gentamicin therapy in urinary tract infection. Antimicrob Agents Chemother 6: 465–470, 1974.

    PubMed  CAS  Google Scholar 

  243. Laferriere CI, Marks MI: Chloramphenicol: properties and clinical use. Pediatr Infect Dis 1: 257, 1982.

    PubMed  CAS  Google Scholar 

  244. LaForce CF, Miller MF, Chai H: Effect of erythromycin on theophylline clearance in asthmatic children. J Pediatr 99: 153–156, 1981.

    PubMed  CAS  Google Scholar 

  245. Lakin JD, Strong DM, Sell KW: Polymyxin B reactions, IgE antibody and T–cell deficiency. Ann Intern Med. 83: 204–207, 1975.

    PubMed  CAS  Google Scholar 

  246. Lakshminarayan S, Sahn SA, Hudson LD: Massive haemolysis caused by rifampicin. Br Med J 2: 282–283, 1973.

    PubMed  CAS  Google Scholar 

  247. Lai S, Singhal SN, Burley DM, et al.: Effect of rifampin and isoniazid on liver function. Br Med J 2: 148–150, 1972.

    Google Scholar 

  248. Lancet–Editorial. Acyclovir. Lancet ii: 845, 1981.

    Google Scholar 

  249. Lasser AE, Steiner MM: Tetracycline photo-onycholysis. Pediatrics 61: 98–99, 1978.

    PubMed  CAS  Google Scholar 

  250. Laxer RM, Mackay E, Marks MI: Antimicrobial activity of tobramycin against gram–negative bacteria and the combination of ampicillin/tobramycin against E. coli. Chemotherapy 21: 90–98, 1975.

    CAS  Google Scholar 

  251. Leary PM, Jones C, Douglas F, et al.: Difetarsone in outpatient treatment of Trichuris trichiura infestation. Arch Dis Child 49: 486–488, 1974.

    PubMed  CAS  Google Scholar 

  252. Leeming RJ: Co-trimoxazole and phenylalanine metabolism. Lancet i: 255, 1980.

    Google Scholar 

  253. Leff RD, Roberts RJ: Host factors influencing the response to antimicrobial agents. Pediatr Clin North Am 30: 93–102, 1983.

    PubMed  CAS  Google Scholar 

  254. Lehr D: Sulfonamide vasculitis. J Clin Pharmacol 12: 181, 1972.

    CAS  Google Scholar 

  255. Lerner AM, Reyes MP, Cone LA, et al.: Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin. Lancet i:l 123–1125, 1983.

    Google Scholar 

  256. Lerner I: Susceptibility of pathogenic actinomycetes to antimicrobial compounds. Antimicrob Agents Chemother 5: 302, 1974.

    PubMed  CAS  Google Scholar 

  257. Lerner PI: Penetration of cephalothin and lincomycin into the cerebrospinal fluid. Am J Med Sci 257: 125, 1969.

    PubMed  CAS  Google Scholar 

  258. Leroy A, Canonne M-A, Fillastre J-P: Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients. Curr Ther Res 16: 878, 1974.

    PubMed  CAS  Google Scholar 

  259. Levin MH, Weinstein RA, Axelrod JL, et al.: Severe, reversible neutropenia during high–dose mebendazole therapy for echinococcosis. JAMA 249: 2929–2931, 1983.

    PubMed  CAS  Google Scholar 

  260. Levy SB: Microbial resistance to antibiotics. An evolving and persistent problem. Lancet ii: 83–88, 1982.

    Google Scholar 

  261. Lewis GP, Jusko WJ: Pharmacokinetics of ampicillin in cirrhosis. Clin Pharmacol Ther 18: 475–484, 1975.

    PubMed  CAS  Google Scholar 

  262. Lewis VJ, Thacker WL, Shepard CC, et al.: In vivo susceptibility of the legionnaires disease bacterium to ten antimicrobial agents. Antimicrob Agents Chemother 13: 419–422, 1978.

    PubMed  CAS  Google Scholar 

  263. Light RB, Ronald AR, Harding GKM, et al.: Trimethoprim alone in the treatment and prophylaxis of urinary tract infections. Arch Intern Med 141: 1807–1810, 1981.

    PubMed  CAS  Google Scholar 

  264. Lloyd–Still JD, Grand RJ, Vawter GF: Tetracycline hepatotoxicity in the differential diagnosis of postoperative jaundice. J Pediatr 84: 366–370, 1974.

    Google Scholar 

  265. Lobo MC, Mandell GL: Treatment of experimental staphylococcal infection with rifampin. Antimicrob Agents Chemother 2: 195, 1972.

    PubMed  CAS  Google Scholar 

  266. Lockwood WR, Bower JD: Tobramycin and gentamicin concentrations in the serum of normal and anephric patients. Antimicrob Agents Chemother 3: 125, 1973.

    PubMed  CAS  Google Scholar 

  267. Lohr JA, Nunley DH, Howards SS, et al.: Prevention of recurrent urinary tract infections in girls. Pediatrics 59: 562–565, 1977.

    PubMed  CAS  Google Scholar 

  268. Loirat P, Rohan J, Baillet A, et al.: Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin. N Engl J Med 299: 915–919, 1978.

    PubMed  CAS  Google Scholar 

  269. London A, Siegel NJ, Zelson JH, et al.: Nephrogenic diabetes insipidus due to demethylchlortetracycline hydrochloride in a child. Pediatrics 61: 91–93, 1978.

    PubMed  CAS  Google Scholar 

  270. Longstreth GF, Newcomer A: Drug–induced malabsorption-neomycin. Mayo Clin Proc 50: 284–293, 1975.

    PubMed  CAS  Google Scholar 

  271. Lowy FD, Chang DS, Lash PR: Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin–resistant, coagulase–negative staphylococci. Antimicrob Agents Chemother 23: 932–934, 1983.

    PubMed  CAS  Google Scholar 

  272. Lwin N, Collipp PJ: Absorption and tolerance of clindamycin-2-palminate in infants below six months of age. Curr Ther Res 12: 648, 1970.

    PubMed  CAS  Google Scholar 

  273. Lynch PJ, Botero F: Sporotrichosis in children. Am J Dis Child 122: 325, 1971.

    PubMed  CAS  Google Scholar 

  274. Madhavan T, Yaremchuk K, Levin N, et al.: Effects of renal failure and dialysis on cefazolin pharmacokinetics. Antimicrob Agents Chemother 8: 63–66, 1975.

    PubMed  CAS  Google Scholar 

  275. Magera BE, Arroyo JC, Rosansky SJ, et al.: Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis. Antimicrob Agents Chemother 23: 710–714, 1983.

    PubMed  CAS  Google Scholar 

  276. Mahmoud AA: Schistosomiasis. N Engl J Med 297: 1329–1331, 1977.

    PubMed  CAS  Google Scholar 

  277. Majeski JA, Alexander JW: Evaluation of tetracycline in the neutrophil chemotactic response. J Lab Clin Med 90: 259–265, 1977.

    PubMed  CAS  Google Scholar 

  278. Malacoff RF, Finkelstein FO, Andriole VT: Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin. Antimicrob Agents Chemother 8: 574–580, 1975.

    PubMed  CAS  Google Scholar 

  279. Malewicz B, Jenkin HM, Borowski E: Dissociation between the induction of potassium efflux and cytostatic activity of polyene macrolides in mammalian cells. Antimicrob Agents Chemother 17: 699–706, 1980.

    PubMed  CAS  Google Scholar 

  280. Mandell GL: Cephaloridine. Ann Intern Med 79: 561–565, 1973.

    CAS  Google Scholar 

  281. Mannisto PT, Mantyla R, Nykanen S, et al.: Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother 21: 730–733, 1982.

    PubMed  CAS  Google Scholar 

  282. Maqbool S, Lawrence D, Katz M: Treatment of trichuriasis with a new drug, mebendazole. J Pediatr 86: 463–465, 1975.

    PubMed  CAS  Google Scholar 

  283. Marker SC, Howard RJ, Groth KE, et al.: A trial of vidarabine for cytomegalovirus infection in renal transplant patients. Arch Intern Med 140: 1441–1444, 1980.

    PubMed  CAS  Google Scholar 

  284. Markowitz M, Gordis L: A mail–in technique for detecting penicillin in urine: application to the study of maintenance of prophylaxis in rheumatic fever patients. Pediatrics 41: 151–153, 1968.

    PubMed  CAS  Google Scholar 

  285. Marks MI, Eickhoff TC: Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med 73: 179–187, 1970.

    PubMed  CAS  Google Scholar 

  286. Marks MI, Eickhoff TC: Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob Agents Chemother 491–493, 1970.

    Google Scholar 

  287. Marks MI, Kazemi M, Mackay E: In vitro susceptibility to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination. Antimicrob Agents Chemother 4: 555–559, 1973.

    PubMed  CAS  Google Scholar 

  288. Marks S, Marks MI, Dupont C, et al.: Evaluation of three antibiotic programs in newborn infants. Can M Assoc J 118: 659–662, 1978.

    CAS  Google Scholar 

  289. Marks MI, Rabinovitch M, Mackenzie R, et al.: Treatment of streptococcal pharyngitis II. In vitro studies of antibacterial activity. Can Med Assoc J 108:1274–1276, 1973.

    Google Scholar 

  290. Marks MI, Steer PL, Eickhoff TC: In Vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine and clotrimazole (Bay 5097). Appl Microbiol 22: 93–95, 1971.

    PubMed  CAS  Google Scholar 

  291. MatsenJM, Koepoke MJH, Quie PG: Evaluation of the Bauer-Kirby-Sherris-Turck single-disc diffusion method of antibiotic susceptibility testing. Antimicrob Agents Chemother 9: 445–453, 1969.

    Google Scholar 

  292. McAllister WAC, Thompson PJ, Al-Habet SM, et al.: Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J 286: 923–925, 1983.

    CAS  Google Scholar 

  293. McCartney CF, Hatley LH, Kessler JM: Possible tobramycin delirium. JAMA 247: 1319, 1982.

    PubMed  CAS  Google Scholar 

  294. McCloskey JR, Chung SMK: Quadriceps contracture as a result of multiple intramuscular injection. Am J Dis Child 131: 416–417, 1977.

    PubMed  CAS  Google Scholar 

  295. McCracken GH Jr: Clinical pharmacology of gentamicin in infants two to twenty–four months of age. Am J Dis Child 124: 884, 1972.

    PubMed  Google Scholar 

  296. McCracken GH Jr: Pharmacological basis for antimicrobial therapy in newborn infants. Am J Dis Child 128: 407–419, 1974.

    PubMed  CAS  Google Scholar 

  297. McCracken GH Jr, Eichenwald HF: Therapy of infectious conditions. Part II. J Pediatr 93: 357–377, 1978.

    PubMed  Google Scholar 

  298. McCracken GH Jr, Ginsburg CM, Chrano DF, et al.: Clinical pharmacology of penicillin in newborn infants. J Pediatr 82: 692–698, 1973.

    PubMed  Google Scholar 

  299. McCracken GH Jr, Ginsburg CM, Clahsen JC, et al.: Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability. Pediatrics 62: 738–743, 1978.

    PubMed  Google Scholar 

  300. McDonald LL, St. Geme JW Jr: Cerebrospinal fluid diffusion of kanamycin in newborn infants. Antimicrob Agents Chemother 2: 41–45, 1972.

    PubMed  CAS  Google Scholar 

  301. McGehee RF Jr, Smith CB, Wilcox C, et al.: Comparative studies of antibacterial activity in vitro and absorption and excretions of lincomycin and clindamycin. Am J Med Sci 256: 279, 1968.

    PubMed  CAS  Google Scholar 

  302. Mead PB, Gibson M, Schentag JJ, et al.: Possible alteration of metronidazole metabolism by phenobarbital. N Engl J Med 306: 1490, 1982.

    PubMed  CAS  Google Scholar 

  303. Med Lett: Handbook of Antimicrobial Therapy, Vol. 14, No. 2, 1972.

    Google Scholar 

  304. Med Lett: Drugs for parasitic infections. 24: 5–12, 1982.

    Google Scholar 

  305. Med Lett: Haloprogin for tinea. 15: 69–70, 1973.

    Google Scholar 

  306. Med Lett: Treatment of sexually transmitted diseases. 24: 29–32, 1982.

    Google Scholar 

  307. Med Lett: Two new oral cephalosporins. 21: 85–87, 1979.

    Google Scholar 

  308. Med Lett: Adverse systemic effects from ophthalmic drugs. 24: 53, 1982.

    Google Scholar 

  309. Med Lett: Adverse interactions of drugs. 17: 17, 1975.

    Google Scholar 

  310. Med Lett: Topical neomycin. 15: 101, 1973.

    Google Scholar 

  311. Med Lett: Clotrimazole (Lotrimin)—a new topical antifungal drug. 17:77– 78, 1975.

    Google Scholar 

  312. Med Lett: Penicillin allergy. 20: 14–15, 1978.

    Google Scholar 

  313. Med Lett: Oral carbenicillin. 15: 371, 1973.

    Google Scholar 

  314. Med Lett: Kwell and other drugs for treatment of lice and scabies. 19:18– 19, 1977.

    Google Scholar 

  315. Med Lett: Clindamycin. 15: 370, 1973.

    Google Scholar 

  316. Med Lett: Adverse interactions of drugs. 23: 17, 1981.

    Google Scholar 

  317. Med Lett: Bacampicillin hydrochloride (Spectrobid). 23: 49–50, 1981.

    Google Scholar 

  318. Med Lett: Griseofulvin: a new formulation and some old concerns. 18:17– 18, 1976.

    Google Scholar 

  319. Med Lett: Trimethoprim–sulfamethoxazole for intravenous infusion. 23: 102–104, 1981.

    Google Scholar 

  320. Med Lett: Immunizations and chemoprophylaxis for travelers. 23: 105–108, 1981.

    Google Scholar 

  321. Med Lett: Monistat I. V. 21: 31–32, 1979.

    Google Scholar 

  322. Med Lett: Piperacillin sodium (Pipracil). 24: 48–49, 1982.

    Google Scholar 

  323. Med Lett: Is Flagyl dangerous? 17: 53–54, 1975.

    Google Scholar 

  324. Med Lett: Tests for penicillin allergy. 17: 54–56, 1974.

    Google Scholar 

  325. Med Lett: Cefazolin sodium. 16: 1, 1974.

    Google Scholar 

  326. Med Lett: Drugs for tuberculosis. 24: 17–18, 1982.

    Google Scholar 

  327. Med Lett: Intravenous acyclovir (Zovirax). 25: 34, 1983.

    Google Scholar 

  328. Melange M, Vanheuverzwyn R, Fiasse R: Pseudomembranous colitis and rifampicin. Lancet ii: 1192, 1980.

    Google Scholar 

  329. Melsom H, Seljelid R: Rifamycin-a potent inhibitor of macrophage cytotoxicity. Exp Cell Res 86: 415–416, 1974.

    PubMed  CAS  Google Scholar 

  330. Mery J-P, Kanfer A: Ototoxicity of erythromycin in patients with renal insufficiency. N Engl J Med 301: 944, 1979.

    PubMed  CAS  Google Scholar 

  331. Meunier-Carpentier F: Treatment of mycoses in cancer patients. Am J Med 74: 74–79, 1983.

    PubMed  CAS  Google Scholar 

  332. Michalsen H, Bergan T: Pharmacokinetics of netilmicin in children with and without cystic fibrosis. Antimicrob Agents Chemother 19: 1029–1031, 1981.

    PubMed  CAS  Google Scholar 

  333. Michel J, Jacobs JY, Sacks T: Bactericidal effect of combinations of antimicrobial drugs and antineoplastic antibiotics against gram-negative bacilli. Antimicrob Agents Chemother 16: 761–766, 1979.

    PubMed  CAS  Google Scholar 

  334. Millet VM, Dreisbach M, Bryson YJ: Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine. Antimicrob Agents Chemother 21: 1–4, 1982.

    PubMed  CAS  Google Scholar 

  335. Moellering RC Jr, Swartz MN: The newer cephalosporins. N Engl J Med 294: 24–28, 1976.

    PubMed  CAS  Google Scholar 

  336. Mohr JA, Clard RM, Waack TC, et al.: Nafcillin-associated hypokalemia. JAMA 242: 544, 1979.

    PubMed  CAS  Google Scholar 

  337. Moller NE: Carbenicillin-induced haemorrhagic cystitis. Lancet ii: 946, 1978.

    Google Scholar 

  338. Moller NE, Hoiby N: Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. Scand J Infect Dis S24: 87–91, 1981.

    Google Scholar 

  339. Monif GRG, Baer H: In vitro susceptibility of bacteroides strains to tetracycline, chloramphenicol, doxycycline and clindamycin. Obstet Gynecol 43: 211, 1974.

    PubMed  CAS  Google Scholar 

  340. Morbid Mortal Wkly Rep: Vestibular reactions to minocycline after meningococcal prophylaxis. 24: 9–11, 1975.

    Google Scholar 

  341. Morbid Mortal Wkly Rep: Problems encountered with using fansidar as prophylaxis for malaria. 31: 232–234, 1982.

    Google Scholar 

  342. Morbid Mortal Wkly Rep: Clindamycin and quinine treatment for Babesia microti infections. 32: 65–72, 1983.

    Google Scholar 

  343. Morehead CD, Shelton S, Kusmiesz H, et al.: Pharmacokinetics of carbenicillin in neonates of normal and low birth weight. Antimicrob Agents Chemother 2: 267, 1972.

    PubMed  CAS  Google Scholar 

  344. Moss JD, Lewis JE, Knauer CM: Isoniazid-associated hepatitis. A study of five cases. Am Rev Respir Dis 106: 849, 1972.

    PubMed  CAS  Google Scholar 

  345. Most H: Treatment of common parasitic infections of man encountered in the United States (Part 1). N Engl J Med 287: 495–498, 1972.

    PubMed  CAS  Google Scholar 

  346. Most H: Treatment of common parasitic infections of man encountered in the United States (Part 2). N Engl J Med 287: 698–702, 1972.

    PubMed  CAS  Google Scholar 

  347. Mull MM: The tetracyclines. Am J Dis Child 112: 483, 1966.

    PubMed  CAS  Google Scholar 

  348. Nair SR, Cherubin CE: Use of cefoxitin, new cephalosporin-like antibiotic, in the treatment of aerobic and anaerobic infections. Antimicrob Agents Chemother 14: 866–875, 1978.

    PubMed  CAS  Google Scholar 

  349. Nair SR, Kaplan JM, Levine LH, et al.: Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis. Ann Intern Med 92: 511, 1980.

    PubMed  CAS  Google Scholar 

  350. Nauta EH, Mattie H, Goslings WRO: Pharmacokinetics of cloxacillin in patients on chronic intermittent haemodialysis and in healthy subjects. Chemotherapy 19: 261, 1973.

    PubMed  CAS  Google Scholar 

  351. Neftel K, Muller MR, Hauser SP: More on penicillin-induced leukopenia. N Engl J Med 308: 901–902, 1983.

    Google Scholar 

  352. Nelson JD: Neonatal ticarcillin dosage. Pediatrics 64: 549–550, 1979.

    PubMed  CAS  Google Scholar 

  353. Nelson JD, Haltalin KC: Amoxicillin less effective than ampicillin against Shigella in vitro and in vivo: relationship of efficacy to activity in serum. J Infect Dis 129: S222–227, 1974.

    PubMed  Google Scholar 

  354. Nelson JD, McCracken GH Jr: The current status of gentamicin for the neonate and young infant. Am J Dis Child 124: 13–16, 1972.

    PubMed  CAS  Google Scholar 

  355. Nelson JD, McCracken GH Jr: Clinical pharmacology of carbenicillin and gentamicin in the neonate and comparative efficacy with ampicillin and gentamicin. Pediatrics 52: 801, 1973.

    PubMed  CAS  Google Scholar 

  356. Nelson JD, McCracken GH Jr: Pediatr Infect Dis Newslett 7: 1, May 1981.

    Google Scholar 

  357. Nelson JD, McCracken GH Jr: Pediatr Infect Dis Newslett 7: 1, August 1981.

    Google Scholar 

  358. Nelson JD, Shelton S, Kusmiersz HT, et al.: Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis. Clin Pharmacol Ther 13: 879, 1972.

    PubMed  CAS  Google Scholar 

  359. Neu HC: In vitro activity and human pharmacology of amoxicillin. J Infect Dis 129: S123–131, 1974.

    PubMed  Google Scholar 

  360. Neu HC, Prince AS: Interaction between moxalactam and alcohol. Lancet i: 1422, 1980.

    Google Scholar 

  361. Neuvonen PJ, Gothoni G, Hackman R, et al.: Interference of iron with the absorption of tetracyclines in man. Br Med J 4: 532, 1970.

    PubMed  CAS  Google Scholar 

  362. Neuvonen PJ, Pentilla O: Interaction between doxycycline and barbiturates. Br Med J 1: 535–537, 1974.

    PubMed  CAS  Google Scholar 

  363. Newfield P, Roizen MF: Hazards of rapid administration of vancomycin. Ann Intern Med 91: 581, 1979.

    PubMed  CAS  Google Scholar 

  364. Newman R, Doster BE, Murray FJ, et al.: Rifampin in initial treatment of pulmonary tuberculosis. Am Rev Respir Dis 109: 216, 1974.

    PubMed  CAS  Google Scholar 

  365. Nies AS: Drug interactions. Med Clin North Am 58: 965–975, 1974.

    PubMed  CAS  Google Scholar 

  366. Nordbring F: Current practice in penicillin dosing. J Antimicrob Chemother 8: 1–6, 1981.

    PubMed  Google Scholar 

  367. O’Brien TF, Hopkins JD, Gilleece ES, et al.: Molecular epidemiology of antibiotic resistance in Salmonella from animals and human beings in the United States. N Engl J Med 307: 1–6, 1982.

    PubMed  Google Scholar 

  368. Oh JH, MacLean LD: Diseases associated with specific HL-A antigens. Can Med Assoc J 112: 1315–1318, 1975.

    PubMed  CAS  Google Scholar 

  369. Ohning BL, Reed MD, Doershuk CF, et al.: Ticarcillin-associated granu-locytopenia. Am J Dis Child 136: 645–646, 1982.

    PubMed  CAS  Google Scholar 

  370. Oldenburg B, Speck WT: Metronidazole. Pediatr Clin North Am 30: 71–75, 1983.

    CAS  Google Scholar 

  371. Olson WA, Pruitt AW, Dayton PG: Plasma concentrations of isoniazid in children with tuberculous infections. Pediatrics 67: 876–878, 1981.

    PubMed  CAS  Google Scholar 

  372. O’Reilly RA: Interaction of chronic daily warfarin therapy and rifampin. Ann Intern Med 83: 506–508, 1975.

    PubMed  Google Scholar 

  373. Orkin Mailbach HI: This scabies pandemic. N Engl J Med 298: 496–498, 1978.

    Google Scholar 

  374. Orr ER, Riley HD: Sporotrichosis in childhood. Report of ten cases. J Pediatr 78: 951–957, 1971.

    PubMed  CAS  Google Scholar 

  375. Palmer DL, Despopoulos A, Rael ED: Induction of chloramphenicol metabolism by phenobarbital. Antimicrob Agents Chemother 1: 112–115, 1972.

    PubMed  CAS  Google Scholar 

  376. Panchi G, Pantosti A, Giunchi G, et al.: Cephalothin, cefoxitin, or metronidazole in elective colonic surgery? A single–blind randomized trial. Dis Colon Rectum 25: 783–786, 1982.

    Google Scholar 

  377. Parry MF, Neu HC, Merlino M, et al.: Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gen– tamicin. J Pediatr 90: 144–148, 1977.

    PubMed  CAS  Google Scholar 

  378. Patamasucon P, Kaojarern S, Kusmiesz H, et al.: Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under four months of age. Antimicrob Agents Chemother 19: 736–739, 1981.

    PubMed  CAS  Google Scholar 

  379. Patrick J, Panzer JD, Derbes VJ: Neomycin sensitivity in the normal (non-atopic) individual. Arch Dermatol 102: 532, 1970.

    PubMed  CAS  Google Scholar 

  380. Patterson RM, Ackerman GL: Renal tubular acidosis due to amphotericin B nephrotoxicity. Arch Intern Med 127: 241, 1971.

    PubMed  CAS  Google Scholar 

  381. Pennington CR: Trimethoprim-sulfamethoxazole. N Engl J Med 303:1533–1534, 1980.

    PubMed  CAS  Google Scholar 

  382. Pennington JE, Block ER, Reynolds HY: 5-Fluorocytosine and amphotericin B in bronchial secretions. Antimicrob Agents Chemother 6: 324–326, 1974.

    PubMed  CAS  Google Scholar 

  383. Pentilla O, Neuvonen PJ, Aho K, et al.: Interaction between doxycycline and some antiepileptic drugs. Br Med J 2: 470–472, 1974.

    Google Scholar 

  384. Phair JP, Watanakunakom C, Bannister T: In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin. Appl Microbiol 18: 303, 1969.

    PubMed  CAS  Google Scholar 

  385. Phillips JB, Satterwhite C, Dworsky ME, et al.: Recommended amikacin doses in newborns often produce excessive serum levels. Pediatr Pharmacol 2: 121–125, 1982.

    Google Scholar 

  386. Phillips KG: Hepatotoxicity of erythromycin ethylsuccinate in a child. Can Med Assoc J 129: 411–412, 1983.

    PubMed  CAS  Google Scholar 

  387. Picardi JL, Lewis HP, Tan JS, et al.: Clindamycin concentrations in the central nervous system of primates before and after head trauma. J Neurosurg 43: 717–720, 1975.

    PubMed  CAS  Google Scholar 

  388. Pitt HA, Roberts RB, Johnson WD Jr: Gentamicin levels in the human biliary tract. J Infect Dis 127: 299, 1973.

    PubMed  CAS  Google Scholar 

  389. Pittinger C, Adamson R: Antibiotic blockade of neuromuscular function. Annu Rev Pharmacol 12: 169, 1972.

    PubMed  CAS  Google Scholar 

  390. Pont A, Williams PL, Loose DS, et al.: Ketoconazole blocks adrenal steroid synthesis. Ann Intern Med 97: 370–372, 1982.

    PubMed  CAS  Google Scholar 

  391. Poor DM, Self TH, Davis HL: Interaction of rifampin and digitoxin. Arch Intern Med 143: 599, 1983.

    PubMed  CAS  Google Scholar 

  392. Postlethwaite AE, Bartel AG, Kelley WN: Hyperuricemia due to ethambutol. N Engl J Med 286: 761–763, 1973.

    Google Scholar 

  393. Pruitt AW, Anyan WR, Hill RM, et al.: The transfer of drugs and other chemicals into human breast milk. Pediatrics 72: 375–383, 1983.

    Google Scholar 

  394. Putzi R, Blaser J, Luthy R, et al.: Side-effects due to the intravenous infusion of erythromycin lactobionate. Infection 11: 161–163, 1983.

    PubMed  CAS  Google Scholar 

  395. Quinn TC, Jacobs RF, Mertz GJ, et al.: Congenital malaria. J Pediatr 101: 229–232, 1982.

    PubMed  CAS  Google Scholar 

  396. Rabinovitch M, MacKenzie R, Brazeau M, et al.: Treatment of streptococcal pharyngitis. I. Clinical evaluation. Can Med Assoc J 108: 1271–1274, 1973.

    PubMed  CAS  Google Scholar 

  397. Rabinovitch M, Pitlik SD, Halevy J, et al.: Ethambutol-induced thrombocytopenia. Chest 81: 765–766, 1982.

    Google Scholar 

  398. Radner DB, Toxicologic and pharmacologic aspects of rifampin. Chest 64: 213, 1973.

    PubMed  CAS  Google Scholar 

  399. Raichle ME, Kutt H, McDowell F: Neurotoxicity of intravenously administered penicillin G. Arch Neurol 25: 232, 1971.

    PubMed  CAS  Google Scholar 

  400. Raleigh JW: Rifampin in treatment of advanced pulmonary tuberculosis. Am Rev Respir Dis 105: 397, 1972.

    PubMed  CAS  Google Scholar 

  401. Ram, MD, Watanatittan S: Cephalothin levels in human bile. Arch Surg 108: 187, 1974.

    PubMed  CAS  Google Scholar 

  402. Ramgopal V, Leronar C, Bhathena D: Acute renal failure associated with rifampicin. Lancet i:l 195–1198, 1973.

    Google Scholar 

  403. Rankin LI, Swain RR, Luft FC: Effect of cephalothin on measurement of creatinine concentration. Antimicrob Agents Chemother 15: 666–669, 1979.

    PubMed  CAS  Google Scholar 

  404. Ratzan, KR, Ruiz C, Irvin III GL: Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease. Antimicrob Agents Chemother 6: 426–431, 1974.

    PubMed  CAS  Google Scholar 

  405. Reeves DS: Sulfamethoxazole/trimethoprim: the first two years. J Clin Pathol 24: 430, 1971.

    PubMed  CAS  Google Scholar 

  406. Reyes MP, Palutke M, Lerner AM: Granulocytopenia associated with carbenicillin. Five episodes in two patients. Am J Med 54: 413, 1973.

    PubMed  CAS  Google Scholar 

  407. Reyn A, Schmidt H, Trier M, et al.: Spectinomycin hydrochloride (Trobicin) in the treatment of gonorrhoea. Br J Vener Dis 49: 54–59, 1973.

    PubMed  CAS  Google Scholar 

  408. Richey GD, Schleupner CJ: Peritoneal fluid concentrations of gentamicin in patients with spontaneous bacterial peritonitis. Antimicrob Agents Chemother 19: 312–315, 1981.

    PubMed  CAS  Google Scholar 

  409. Riegelman S, Rowland M, Epstein WL: Griseofulvin-phenobarbital interaction in man. JAMA 213: 426–431, 1970.

    PubMed  CAS  Google Scholar 

  410. Ries CA, Rosenbaum TJ, Garratty G, et al.: Penicillin-induced immune hemolytic anemia. JAMA 233: 432–435, 1975.

    PubMed  CAS  Google Scholar 

  411. Riff LJ, Jackson GG: Laboratory and clinical conditions for gentamicin inactivation by carbenicillin. Arch Intern Med 130: 887, 1972.

    PubMed  CAS  Google Scholar 

  412. Riley HD Jr: Pharmacology for the pediatrician, drug interactions — Part IV. Interactions among antimicrobial and nonantimicrobial agents. Pediatrics 50: 954–955, 1972.

    PubMed  CAS  Google Scholar 

  413. Roe DA: Drug-nutrient interactions. Resident Staff Phys 42–48, July 1981.

    Google Scholar 

  414. Romagnoli MF, Flynn K, Siber GR, et al.: Moxalactam pharmacokinetics in children. Antimicrob Agents Chemother 22: 47–50, 1982.

    PubMed  CAS  Google Scholar 

  415. Rosenfeld J, Gura V, Boner G., et al.: Interstitial nephritis with acute renal failure after erythromycin. Br Med J 286: 938–939, 1983.

    CAS  Google Scholar 

  416. Rothfield NF, Bierer WF, Garfield JW: Isoniazid induction of antinuclear antibodies. A prospective study. Ann Intern Med 88: 650–652, 1978.

    PubMed  CAS  Google Scholar 

  417. Roupe G, Strannegard O: Anaphylactic shock elicited by topical administration of bacitracin. Arch Dermatol 100: 450, 1969.

    PubMed  CAS  Google Scholar 

  418. Rubin DH, Carbone J, Fong B, et al.: Chronic isoniazid poisoning. Clin Pediatr 22: 518–519, 1983.

    CAS  Google Scholar 

  419. Rudoy RC, Nelson JD, Haltalin KC: In vitro susceptibility of Shigella strains to trimethoprim and sulfamethoxazole. Antimicrob Agents Chemother 5: 439–443, 1974.

    PubMed  CAS  Google Scholar 

  420. Rudoy RC, Stuemky J, Poley R: Isoniazid administration and liver injury. Am J Dis Child 125: 733–736, 1973.

    PubMed  CAS  Google Scholar 

  421. Ruley EJ, Lisi LM: Interstitial nephritis and renal failure due to ampicillin. J Pediatr 84: 878–881, 1974.

    PubMed  CAS  Google Scholar 

  422. RussoJC, Adelman RD: Gentamicin-induced Fanconi syndrome. J Pediatr 96: 151–153, 1980.

    Google Scholar 

  423. Rymer E, Greenlaw CW: Hypoprothrombinemia associated with cefamandole. Drug Intelligence Clin Pharmacol 14: 780–784, 1980.

    Google Scholar 

  424. Rynearson TK, Shronts JS, Wolinsky E: Rifampin: In vitro effect on atypical mycobacteria. Am Rev Respir Dis 104: 272, 1971.

    PubMed  CAS  Google Scholar 

  425. Saah AJ, Koch TR, Drusano GL: Cefoxitin falsely elevates creatinine levels. JAMA 247: 205–206, 1982.

    PubMed  CAS  Google Scholar 

  426. Sabath LD, Gerstein DA, Finland M: Serum glutamic oxalacetic transaminase. False elevations during administration of erythromycin. N Engl J Med 279: 1137–1139, 1968.

    PubMed  CAS  Google Scholar 

  427. Sacks SL, Scullard GH, Pollard RB, et al.: Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination. Antimicrob Agents Chemother 21: 93–100, 1982.

    PubMed  CAS  Google Scholar 

  428. Saginur R, Hawley CR, Bartlett JG: Colitis associated with metronidazole therapy. J Infect Dis 141: 772–774, 1980.

    PubMed  CAS  Google Scholar 

  429. Sandberg M, Tuazon CU, Sheagren JN: Neutropenia probably resulting from nafcillin. JAMA 232: 1152–1154, 1975.

    PubMed  CAS  Google Scholar 

  430. Sanders WE, Johnson JE, Taggart JG: Adverse reactions to cephalothin and cephapirin. N Engl J Med 290: 424–129, 1974.

    PubMed  CAS  Google Scholar 

  431. Sanders WJ, Wolinsky E: In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents. Antimicrob Agents Chemother 18: 529–531, 1982.

    Google Scholar 

  432. Sanjad SA, Haddad GG, Nassar VH: Nephropathy, an underestimated complication of methicillin therapy. J Pediatr 84: 873–877, 1974.

    PubMed  CAS  Google Scholar 

  433. Santos JI, Swenson P, Glasgo LA: Potentiation of Clostridium botulinum toxin by aminoglycoside antibiotics: clinical and laboratory observations. Pediatrics 68: 50–54, 1981.

    PubMed  CAS  Google Scholar 

  434. Schaad UB, McCracken GH Jr, Nelson JD: Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr 96: 119–126, 1980.

    PubMed  CAS  Google Scholar 

  435. Schaad UB, McCracken GH Jr, Threlkeld N, et al.: Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr 98: 129–136, 1981.

    PubMed  CAS  Google Scholar 

  436. Scheifele DW: Prophylactic antibiotics in children. Pediatr Infect Dis 1:420– 424, 1982.

    Google Scholar 

  437. Schonebeck J, Polak A, Fernex M, et al.: Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function. Chemotherapy 18: 321, 1973.

    PubMed  CAS  Google Scholar 

  438. Schonell M, Dorken E, Grzybowski S: Rifampin. Can Med Assoc J 106: 783, 1972.

    CAS  Google Scholar 

  439. Schoutens E, Peromet ES, Yourassowsky E: Microbiological and clinical study of spectinomycin in urinary tract infections: Reevaluation with hospital strains. Curr Ther Res 14: 349, 1972.

    PubMed  CAS  Google Scholar 

  440. Sheehan J: Trimethoprimssociated marrow toxicity. Lancet ii: 692, 1981.

    Google Scholar 

  441. Sher TH: Penicillin hypersensitivity-a review. Pediatr Clin North Am 30: 161–176, 1983.

    PubMed  CAS  Google Scholar 

  442. Shope JT: Medication compliance. Pediatr Clin North Am 28: 5–21, 1981.

    PubMed  CAS  Google Scholar 

  443. Siber GR, Echeverria P, Smith AL, et al.: Pharmacokinetics of gentamicin in children and adults. J Infect Dis 132: 637–651, 1975.

    PubMed  CAS  Google Scholar 

  444. Siegler DI, Bryant M, Burley DM, et al.: Effect of meals on rifampicin absorption. Lancet ii: 197–198, 1974.

    Google Scholar 

  445. Sinclair D, Phillips C: Transient myopathy apparently due to tetracycline. N Engl J Med 307: 821–822, 1982.

    PubMed  CAS  Google Scholar 

  446. Sippel JE, Mikhail IA, Girgis NI, et al.: Rifampin concentrations in cerebrospinal fluid of patients with tuberculous meningitis. Am Rev Respir Dis 109: 579–580, 1974.

    PubMed  CAS  Google Scholar 

  447. Sirnavin S, McCracken GH Jr, Nelson JD: Determining gentamicin dosage in infants and children with renal failure. J Pediatr 96: 331–334, 1980.

    Google Scholar 

  448. Smilack JD, Burgin WW, Moore WL, et al.: Mycoplasma pneumoniae pneumonia and clindamycin therapy. JAMA 228: 729–731, 1974.

    PubMed  CAS  Google Scholar 

  449. Smith CB, Friedewald WT, Chanock RM: Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med 276: 1172–1175, 1967.

    PubMed  CAS  Google Scholar 

  450. Smith CR, Lietman PS: Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans. Antimicrob Agents Chemother 23: 133–137, 1983.

    PubMed  CAS  Google Scholar 

  451. Smith CR, Lipsky JJ, Laskin OL, et al.: Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 302: 1106–1109, 1980.

    PubMed  CAS  Google Scholar 

  452. Smith EJ, Light JA, Filo RS, et al.: Interstitial nephritis caused by trimethoprim-sulfamethoxazole in renal transplant recipients. JAMA 244: 360–361, 1980.

    PubMed  CAS  Google Scholar 

  453. Smithurst BA: Spectinomycin for the treatment of gonorrhoea at Brisbane, Australia. NZ Med J 447: 82, 1972.

    Google Scholar 

  454. Soule BM, Ahtone J: Contact lenses and rifampin. APIC Assoc. for Practitioners & Infect Control. Note: In 1980 this was changed to AJIC American Journal of Infection Control 1: 24, 1979.

    Google Scholar 

  455. Speer ME, Mason EO, Scharnberg JT: Cerebrospinal fluid concentrations of aqueous procaine penicillin G in the neonate. Pediatrics 67: 387–388, 1981.

    PubMed  CAS  Google Scholar 

  456. Speer ME, Taber LH, Clark DB, et al.: Cerebrospinal fluid levels of benzathine penicillin G in the neonate. J Pediatr 91: 996–997, 1977.

    PubMed  CAS  Google Scholar 

  457. Spencer MJ: Cefaclor in the treatment of susceptible infections in infants and children. Infection 7: S628, 1979.

    Google Scholar 

  458. Spitalny KC, Senft AW, Meglio FD, et al.: Treatment of pulmonary paragonimiasis with a new broad spectrum antihelmintic, Praziquantel. J Pediatr 110: 144–146, 1982.

    Google Scholar 

  459. Springer C, Eyal F, Michel J: Pharmacology of trimethoprim-sulfamethoxazole in newborn infants. J Pediatr 100: 647–650, 1982.

    PubMed  CAS  Google Scholar 

  460. Sprott MS, Ingham HR, Hickman JE, et al.: Metronidazole-resistant anaerobes. Lancet i: 1220, 1983.

    Google Scholar 

  461. St. John MA, Prober CG: Side effects of cloxacillin in infants and children. Can Med Assoc J 125: 458–460, 1981.

    PubMed  CAS  Google Scholar 

  462. Steer PL, Marks MI, Klite PD, et al.: 5-Fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med 75: 15–19, 1972.

    Google Scholar 

  463. Stegink LD, Boaz DP, Von Behren P: Ampicillin and amino acid chromatography. J Pediatr 81: 1214–1216, 1972.

    PubMed  CAS  Google Scholar 

  464. Stein JB, Tolle SW: Episodic leukopenia associated with amphotericin B. South Med J 76: 409–410, 1983.

    PubMed  CAS  Google Scholar 

  465. Stevenson DK, Christie DL, Haas JE: Hepatic injury in a child caused by trimethoprim-sulfamethoxazole. Pediatrics 61: 864–866, 1981.

    Google Scholar 

  466. Stewart D, Bodey GP: Azlocillin: In vitro studies of a new semisynthetic penicillin. Antimicrob Agents Chemother 11: 865–870, 1977.

    PubMed  CAS  Google Scholar 

  467. Stewart GT: Hypersensitivity and toxicity of the (3 lactam antibiotics, Postgrad Med J (Suppl) 43: 31, 1967.

    CAS  Google Scholar 

  468. Stewart SM, Anderson IME, Jones GR, et al.: Amoxicillin levels in sputum, serum and saliva. Thorax 29: 110, 1974.

    PubMed  CAS  Google Scholar 

  469. Stille W: Dose-activity relationships in chemotherapy. Infection 8: S14–S20, 1980.

    Google Scholar 

  470. Stratton CW, Weinstein MP, Reller LB: Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis 145: 160–168, 1982.

    PubMed  CAS  Google Scholar 

  471. Strausbaugh LJ, Sande MA: Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. J Infect Dis 137: 251–260, 1978.

    PubMed  CAS  Google Scholar 

  472. Stroechlein JR, Sedlack RE, Hoffman HN, et al.: Clindamycin associated colitis. Mayo Clinic Proc 49: 240, 1974.

    Google Scholar 

  473. Sud IJ, Feingold DS: Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans. Antimicrob Agents Chemother 23:185– 187, 1983.

    Google Scholar 

  474. Sugarman B, Pesanti E: Treatment failures secondary to in vivo development of drug resistence by microorganisms. Rev Infect Dis 2: 153–168, 1980.

    PubMed  CAS  Google Scholar 

  475. Swenson JM, Thornsberry C, McCroskey LM, et al.: Susceptibility of Clostridium botulinum to thirteen antimicrobial agents. Antimicrob Agents Chemother 18: 13–19, 1980.

    PubMed  CAS  Google Scholar 

  476. Symposium on Oral indanyl carbenicillin in the treatment of urinary tract infection. J Infect Dis 122 ( Suppl ): May 1973.

    Google Scholar 

  477. Szefler SJ, Wynn RJ, Clarke DF, et al.: Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates. J Pediatr 97: 312–315, 1980.

    PubMed  CAS  Google Scholar 

  478. Talbot MD: Fixed genital drug eruption. Pract Med 224: 823–824, 1980.

    CAS  Google Scholar 

  479. Tally FP, Cuchural GJ, Jacobus NV, et al.: Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother 23: 536–540, 1983.

    PubMed  CAS  Google Scholar 

  480. Tan J, Bayne LH, McLeod PJ: Pseudomembranous colitis. A fatal case following prophylactic cephaloridine therapy. JAMA 247: 749–750, 1982.

    Google Scholar 

  481. Tartas NE, Bullorsky EO, Hevia JEJ, et al.: Pancytopenia induced by ce phalothin. JAMA 245: 1148–1149, 1981.

    PubMed  CAS  Google Scholar 

  482. Tchao P, Templeton T: Thiabendazole-associated grand mal seizures in a patient with Down syndrome. J Pediatr 102: 317–318, 1983.

    PubMed  CAS  Google Scholar 

  483. Tedesco FJ, Stanley RJ, Alpers DH: Diagnostic features of clindamycin-associated pseudomembranous colitis. N Engl J Med 290: 841–843, 1974.

    PubMed  CAS  Google Scholar 

  484. Tetzlaf FTR, McCracken GH Jr, Thomas ML: Bioavailability of cephalexin in children: relationship to drug formulations and meals. J Pediatr 92:292– 294, 1978.

    Google Scholar 

  485. Thirumoorthi MC, Asmar BI, Buckley JA, et al.: Pharmacokinetics of intravenously administered piperacillin in preadolescent children. J Pediatr 102: 941–946, 1983.

    PubMed  CAS  Google Scholar 

  486. Thornsberry C, Baker CN, Facklam RR: Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Antimicrob Agents Chemother 5: 228, 1974.

    PubMed  CAS  Google Scholar 

  487. Tillman DB, Oill PA, Guze LB: Oxacillin nephritis. Arch Intern Med 140: 1152, 1980.

    Google Scholar 

  488. Tomasz A: From Penicillin binding proteins to the lysis and death of bacteria: a 1979 view. Rev Infect Dis 1: 434–467, 1979.

    PubMed  CAS  Google Scholar 

  489. Traber PG, Levine DP: Vancomycin ototoxicity in a patient with normal renal function. Ann Intern Med 95: 458–460, 1981.

    PubMed  CAS  Google Scholar 

  490. True RJ: Interactions between antibiotics and oral contraceptives. JAMA 247: 1408, 1982.

    PubMed  CAS  Google Scholar 

  491. Tulloch AL: Pancytopenia in an infant associated with sulfamethoxazole trimethoprim therapy. J Pediatr 88: 499–500, 1976.

    PubMed  CAS  Google Scholar 

  492. Utz JP, Garriques IL, Sande MA, et al.: Therapy of cryptococcosis with a combination of flucytosine and amphotericin B.J Infect Dis 132: 368–373, 1975.

    CAS  Google Scholar 

  493. Vainrub B, Musher DM: Lack of effect of methenamine in suppression of, or prophylaxis against, chronic urinary infection. Antimicrob Agents Chemother 12: 625–629, 1977.

    PubMed  CAS  Google Scholar 

  494. Van Petten GR, Becking GC, Withey RJ, et al.: Studies on the physiological availability and metabolism of sulfonamides. I. Sulfadiazine. J Clin Pharmacol 11: 27, 1971.

    Google Scholar 

  495. Van Petten GR, Becking GC, Withey RJ, et al.: Studies on the physiological availability and metabolism of sulfonamides. II. Sulfisoxazole. J Clin Pharmacol 11: 35, 1971.

    Google Scholar 

  496. Vandervelde AG, Mauceri AR, Johnson III JE: 5-Fluorocytosine in the treatment of mycotic infections. Ann Intern Med 77: 43–54, 1972.

    Google Scholar 

  497. Vanhoof R, Gordts B, Dierickx R, et al.: Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother 18: 118–121, 1980.

    PubMed  CAS  Google Scholar 

  498. Viteri AL, Howard PH, Dyck WP: The spectrum of lincomycin clindamycin colitis. Gastroenterology 66: 1137–1144, 1974.

    PubMed  CAS  Google Scholar 

  499. Vogelstein B, Kowarski AA, Lietman PS: The pharmacokinetics of amikacin in children. J Pediatr 91: 333–339, 1977.

    PubMed  CAS  Google Scholar 

  500. WadeJC, Meyers JD: Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation. Ann Intern Med 98: 921–925, 1983.

    Google Scholar 

  501. Walker SH, Patron LR: Colistin therapy in infants and children. Am J Dis Child 109: 204–208, 1965.

    PubMed  CAS  Google Scholar 

  502. Walker SH, Salanio I, Standiford WE: Nalidixic acid in childhood urinary tract infection. Clin Pediatr 5: 718, 1966.

    CAS  Google Scholar 

  503. Wallace Jr. RJ, Wiss K.: Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides. Antimicrob Agents Chemother 20: 610–612, 1981.

    PubMed  CAS  Google Scholar 

  504. Wallerstein RO, Condit PK, Kasper CK, et al.: Stateside study of chloramphenicol therapy and fatal aplastic anemia. JAMA 208: 2045–2050, 1969.

    PubMed  CAS  Google Scholar 

  505. Wallwork J, McGregor CGA, Wells RC, et al.: Cyclosporin and intravenous sulphadimidine and trimethoprim therapy. Lancet i: 366–367, 1983.

    Google Scholar 

  506. Walzer PD, Perl DP, Krogstad DJ, et al.: Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic and clinical features. Ann Intern Med 80: 83–86, 1974.

    PubMed  CAS  Google Scholar 

  507. Wang EEL, Prober CG: Ventricular cerebrospinal fluid concentrations of trimethoprim sulfamethoxazole. J Antimicrob Chemother 11: 385–389, 1983.

    PubMed  CAS  Google Scholar 

  508. Washington IIJ A, Yu PKW: In vitro antibacterial activity of spectinomycin. Antimicrob Agents Chemother 2: 427–430, 1972.

    PubMed  CAS  Google Scholar 

  509. Wason S, Lacouture PG, Lovejoy FH Jr.: Single high-dose pyridoxine treatment for isoniazid overdose. JAMA 246: 1102–1104, 1982.

    Google Scholar 

  510. Watanakunakorn C, Guerriero JC: Interaction between vancomycin and rifampin against Staphylococcus aureus. Antimicrob Agents Chemother 19: 1089–1091, 1981.

    PubMed  CAS  Google Scholar 

  511. Weinstein AJ, Moellering RC Jr.: Penicillin and gentamicin therapy for enterococcal infections. JAMA 223: 1030–1032, 1973.

    PubMed  CAS  Google Scholar 

  512. Weir MR, Fearnow RG: Transverse myelitis and penicillin. Pediatrics 71: 988, 1983.

    PubMed  CAS  Google Scholar 

  513. Weitekamp MR, Aber RC: Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA 249: 69–71, 1983.

    PubMed  CAS  Google Scholar 

  514. Westenfelder GO, Paterson PY, Reisberg BE, et al.: Vancomycin-streptomycin synergism in enterococcal endocarditis. JAMA 223: 37–39, 1973.

    PubMed  CAS  Google Scholar 

  515. Western KA, Perera DR, Schultz MG: Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Ann Intern Med 73: 695, 1970.

    PubMed  CAS  Google Scholar 

  516. Whelton A, Carter GG, Bryant HH, et al.: Carbenicillin concentrations in normal and diseased kidneys. A. Therapeutic consideration. Ann Intern Med 78: 659, 1973.

    PubMed  CAS  Google Scholar 

  517. Whitley R, Alford C, Hess F, et al.: Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. Drugs 20: 267–282, 1980.

    PubMed  CAS  Google Scholar 

  518. Whitley RJ, Soong S-J, Dolin R, et al.: Adenine arabinoside therapy of biopsy-proved Herpes simplex encephalitis. N Engl J Med 297: 289–297, 1977.

    PubMed  CAS  Google Scholar 

  519. Wiedemann B: Microbiological basis of antibiotic therapy. Infection 8:S6– 13, 1980.

    Google Scholar 

  520. Williams DN, Crossley K, Hoffman C, et al.: Parenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococci. Antimicrob Agents Chemother 7: 153–158, 1975.

    PubMed  CAS  Google Scholar 

  521. Wilson FM, Belamaric J, Lauter CB, et al.: Anicteric carbenicillin hepatitis. Eight episodes in four patients. JAMA 232: 818–821, 1975.

    PubMed  CAS  Google Scholar 

  522. Wilson JF, Rausch RL: Alveolar hydatid disease. A review of clinical features of 33 indigenous cases of Echinococcus multilocularis infection in Alaskan eskimos. Am J Trop Med Hyg 29: 1340–1355, 1980.

    PubMed  CAS  Google Scholar 

  523. Winklestein A, Ruben FL, Fotiadis IG: Immunological responsiveness of tuberculosis patients receiving rifampicin. Antimicrob Agents Chemother 5: 383, 1974.

    Google Scholar 

  524. Winn Capt RE, Bower Maj JH, Richards Maj JF: Acute toxic delirium. Neurotoxicity of intrathecal administration of amphotericin B. Arch Intern Med 139: 706–707, 1979.

    Google Scholar 

  525. Winston DJ, Murphy W, Young LS, et al.: Piperacillin therapy for serious bacterial infections. Am J Med 69: 255–261, 1980.

    PubMed  CAS  Google Scholar 

  526. Winters RE, Chow AW, Hecht RH, et al.: Combined use of gentamicin and carbenicillin. Ann Intern Med 75: 925, 1971.

    PubMed  CAS  Google Scholar 

  527. Withey RJ, Van Petten GR, Lettau HF: Studies on the physiological availability and metabolism of sulfonamides. III. Triple sulfa. J Clin Pharmacol 12: 190, 1972.

    CAS  Google Scholar 

  528. Wittner M, Rowin KS, Tanowitz HB, et al.: Successful chemotherapy of transfusion babesiosis. Ann Intern Med 96: 601–604, 1982.

    PubMed  CAS  Google Scholar 

  529. Wolfe MS: Giardiasis. Pediatr Clin North Am 26: 295–303, 1979.

    CAS  Google Scholar 

  530. Wong KY, Boose GM, Issitt CH: Erythromycin-induced hemolytic anemia. J Pediatr 98: 647–649, 1981.

    PubMed  CAS  Google Scholar 

  531. Wright DG, Robichaud KJ, Pizzo PA, et al.: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 304: 1185–1189, 1981.

    PubMed  CAS  Google Scholar 

  532. Wyatt RG, Okamoto GA, Feigin RD: Stability of antibiotics in parenteral solutions. Pediatrics 49: 22, 1972.

    PubMed  CAS  Google Scholar 

  533. Yee MH, Guiney DG, Hasegawa P et al.: The clinical significance of clindamycin-resistant Bacteroides fragilis. JAMA 248: 1860–1863, 1982.

    PubMed  CAS  Google Scholar 

  534. Yogev R, Rolling WM: Intraventricular levels of amikacin after intravenous administration. Antimicrob Agents Chemother 20: 583–586, 1981.

    PubMed  CAS  Google Scholar 

  535. Yogev R, Schreiber M, Gardner S, et al.: Moxalactam in the treatment of pediatric infections. Am J Dis Child 136: 836–839, 1982.

    PubMed  CAS  Google Scholar 

  536. Yu VL, Felegie TP, Yee RB, et al.: Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. J Infect Dis 142: 602–607, 1980.

    PubMed  CAS  Google Scholar 

  537. Zaske DE, Sawchuk RJ, Strate RG: The necessity of increased doses of amikacin in burn patients. Surgery 84: 603–608, 1978.

    PubMed  CAS  Google Scholar 

  538. Zenk KE, Dungy CI, Greene GR: Nafcillin extravasation injury. Use of hyaluronidase as an antidote. Am J Dis Child 135: 1113–1114, 1981.

    PubMed  CAS  Google Scholar 

  539. Zinner SH, Casey JI, Sabath LD, et al.: Erythromycin and alkalinisation of the urine in the treatment of urinary tract infections due to gram-negative bacilli. Lancet i: 1267, 1971. 487, 1978.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine, University of Oklahoma, 940 Northeast 13th Street, 73190, Oklahoma City, Oklahoma, USA

    Melvin I. Marks M.D.

  2. Department of Pediatrics, Oklahoma Children’s Memorial Hospital, 940 Northeast 13th Street, 73190, Oklahoma City, Oklahoma, USA

    Melvin I. Marks M.D.

Authors
  1. Melvin I. Marks M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Marks, M.I. (1985). Antimicrobial Therapy. In: Pediatric Infectious Diseases for the Practitioner. Comprehensive Manuals in Pediatrics. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5038-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-5038-8_2

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-9535-8

  • Online ISBN: 978-1-4612-5038-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation